<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:02:47Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5082570" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5082570</identifier><datestamp>2016-11-09</datestamp><setSpec>blackwellopen</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">FEBS J</journal-id>
      <journal-id journal-id-type="iso-abbrev">FEBS J</journal-id>
      <journal-id journal-id-type="doi">10.1111/(ISSN)1742-4658</journal-id>
      <journal-id journal-id-type="publisher-id">FEBS</journal-id>
      <journal-title-group>
        <journal-title>The Febs Journal</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1742-464X</issn>
      <issn pub-type="epub">1742-4658</issn>
      <publisher>
        <publisher-name>John Wiley and Sons Inc.</publisher-name>
        <publisher-loc>Hoboken</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5082570</article-id>
      <article-id pub-id-type="pmcid">PMC5082570</article-id>
      <article-id pub-id-type="pmc-uid">5082570</article-id>
      <article-id pub-id-type="pmid">27486859</article-id>
      <article-id pub-id-type="doi">10.1111/febs.13828</article-id>
      <article-id pub-id-type="publisher-id">FEBS13828</article-id>
      <article-categories>
        <subj-group subj-group-type="overline">
          <subject>Original Article</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Structure and biochemical properties of recombinant human dimethylglycine dehydrogenase and comparison to the diseaseârelated H109R variant</article-title>
        <alt-title alt-title-type="left-running-head">P. Augustin <italic>et al</italic>.</alt-title>
      </title-group>
      <contrib-group>
        <contrib id="febs13828-cr-0001" contrib-type="author">
          <name>
            <surname>Augustin</surname>
            <given-names>Peter</given-names>
          </name>
          <xref ref-type="aff" rid="febs13828-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
        <contrib id="febs13828-cr-0002" contrib-type="author">
          <name>
            <surname>Hromic</surname>
            <given-names>Altijana</given-names>
          </name>
          <xref ref-type="aff" rid="febs13828-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="febs13828-cr-0003" contrib-type="author">
          <name>
            <surname>PavkovâKeller</surname>
            <given-names>Tea</given-names>
          </name>
          <xref ref-type="aff" rid="febs13828-aff-0003">
<sup>3</sup>
</xref>
        </contrib>
        <contrib id="febs13828-cr-0004" contrib-type="author">
          <name>
            <surname>Gruber</surname>
            <given-names>Karl</given-names>
          </name>
          <xref ref-type="aff" rid="febs13828-aff-0002">
<sup>2</sup>
</xref>
        </contrib>
        <contrib id="febs13828-cr-0005" contrib-type="author" corresp="yes">
          <name>
            <surname>Macheroux</surname>
            <given-names>Peter</given-names>
          </name>
          <address>
            <email>peter.macheroux@tugraz.at</email>
          </address>
          <xref ref-type="aff" rid="febs13828-aff-0001">
<sup>1</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="febs13828-aff-0001">
        <label>
          <sup>1</sup>
        </label>
        <named-content content-type="organisation-division">Institute of Biochemistry</named-content>
        <institution>Graz University of Technology</institution>
        <country country="AT">Austria</country>
      </aff>
      <aff id="febs13828-aff-0002">
        <label>
          <sup>2</sup>
        </label>
        <named-content content-type="organisation-division">Institute of Molecular Biosciences</named-content>
        <institution>University of Graz</institution>
        <country country="AT">Austria</country>
      </aff>
      <aff id="febs13828-aff-0003">
        <label>
          <sup>3</sup>
        </label>
        <institution>Austrian Centre of Industrial Biotechnology</institution>
        <country country="AT">Austria</country>
      </aff>
      <author-notes>
        <corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
P. Macheroux, Institute of Biochemistry, Graz University of Technology, Petersgasse 12/II, Aâ8010 Graz, Austria<break/>
Fax: +43 (0)316 873 6952<break/>
Tel: +43 (0)316 873 6450<break/>
Eâmail: <email>peter.macheroux@tugraz.at</email><break/></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>06</day>
        <month>10</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>10</month>
        <year>2016</year>
      </pub-date>
      <volume>283</volume>
      <issue>19</issue>
      <issue-id pub-id-type="doi">10.1111/febs.2016.283.issue-19</issue-id>
      <fpage>3587</fpage>
      <lpage>3603</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>6</month>
          <year>2016</year>
        </date>
        <date date-type="rev-recd">
          <day>25</day>
          <month>7</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>01</day>
          <month>8</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2016 Federation of European Biochemical Societies <copyright-statement>-->
        <copyright-statement content-type="article-copyright">Â© 2016 The Authors. <italic>The FEBS Journal</italic> published by John Wiley &amp; Sons Ltd on behalf of Federation of European Biochemical Societies.</copyright-statement>
        <license license-type="creativeCommonsBy">
          <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:FEBS-283-3587.pdf"/>
      <abstract id="febs13828-abs-0001">
        <sec id="febs13828-sec-0001">
          <p>The human dimethylglycine dehydrogenase (<styled-content style="fixed-case">hDMGDH</styled-content>) is a flavin adenine dinucleotide (<styled-content style="fixed-case">FAD</styled-content>)â and tetrahydrofolate (<styled-content style="fixed-case">THF</styled-content>)âdependent, mitochondrial matrix enzyme taking part in choline degradation, oneâcarbon metabolism and electron transfer to the respiratory chain. The rare natural variant H109R causes dimethylglycine dehydrogenase deficiency leading to increased blood and urinary dimethylglycine concentrations. A detailed biochemical and structural characterization of <styled-content style="fixed-case">hDMGDH</styled-content> was thus far hampered by insufficient heterologous expression of the protein. In the present study, we report the development of an intracellular, heterologous expression system in <italic>Komagataella phaffii</italic> (formerly known as <italic>Pichia pastoris</italic>) providing the opportunity to determine kinetic parameters, spectroscopic properties, thermostability, and the redox potential of <styled-content style="fixed-case">hDMGDH</styled-content>. Moreover, we have successfully crystallized the wildâtype enzyme and determined the structure to 3.1âÃ resolution. The structureâbased analysis of our biochemical data provided new insights into the kinetic properties of the enzyme in particular with respect to oxygen reactivity. A comparative study with the H109R variant demonstrated that the variant suffers from decreased protein stability, cofactor saturation, and substrate affinity.</p>
        </sec>
        <sec id="febs13828-sec-0002">
          <title>Database</title>
          <p>Structural data are available in the <styled-content style="fixed-case">PDB</styled-content> database under the accession number <ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L46">5L46</ext-link>.</p>
        </sec>
      </abstract>
      <kwd-group kwd-group-type="author-generated">
        <kwd id="febs13828-kwd-0001">electron transfer</kwd>
        <kwd id="febs13828-kwd-0002">flavin adenine dinucleotide</kwd>
        <kwd id="febs13828-kwd-0003">genetic disease</kwd>
        <kwd id="febs13828-kwd-0004">recombinant protein expression</kwd>
        <kwd id="febs13828-kwd-0005">Xâray crystallography</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>Austrian Science Foundation (FWF)</funding-source>
        </award-group>
      </funding-group>
      <counts>
        <fig-count count="12"/>
        <table-count count="4"/>
        <page-count count="17"/>
        <word-count count="11170"/>
      </counts>
      <custom-meta-group>
        <custom-meta>
          <meta-name>source-schema-version-number</meta-name>
          <meta-value>2.0</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>component-id</meta-name>
          <meta-value>febs13828</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>cover-date</meta-name>
          <meta-value>October 2016</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>details-of-publishers-convertor</meta-name>
          <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.7 mode:remove_FC converted:10.11.2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <def-list list-content="abbreviations" id="febs13828-dl-0001">
      <title>Abbreviations</title>
      <def-item>
        <term><italic>Ag</italic>DMGO</term>
        <def>
          <p>
<italic>Arthrobacter globiformis</italic> dimethylglycine oxidase</p>
        </def>
      </def-item>
      <def-item>
        <term>DCPIP</term>
        <def>
          <p>2,6âdichlorophenolindophenol</p>
        </def>
      </def-item>
      <def-item>
        <term>DMG</term>
        <def>
          <p>dimethylglycine</p>
        </def>
      </def-item>
      <def-item>
        <term>DMGDH</term>
        <def>
          <p>dimethylglycine dehydrogenase</p>
        </def>
      </def-item>
      <def-item>
        <term>ETFâQO</term>
        <def>
          <p>ETFâubiquinone oxidoreductase</p>
        </def>
      </def-item>
      <def-item>
        <term>hDMGDH</term>
        <def>
          <p>human dimethylglycine dehydrogenase</p>
        </def>
      </def-item>
      <def-item>
        <term>hETF</term>
        <def>
          <p>human electronâtransferring flavoprotein</p>
        </def>
      </def-item>
      <def-item>
        <term>hMCAD</term>
        <def>
          <p>human mediumâchain acylâCoA dehydrogenase</p>
        </def>
      </def-item>
      <def-item>
        <term>MRE</term>
        <def>
          <p>mean residue ellipticity</p>
        </def>
      </def-item>
      <def-item>
        <term>PMS</term>
        <def>
          <p>phenazine methosulfate</p>
        </def>
      </def-item>
      <def-item>
        <term>THF</term>
        <def>
          <p>tetrahydrofolate</p>
        </def>
      </def-item>
      <def-item>
        <term>WT</term>
        <def>
          <p>wildâtype</p>
        </def>
      </def-item>
    </def-list>
    <sec id="febs13828-sec-0003">
      <title>Introduction</title>
      <p>The human flavoproteome comprises 90 enzymes with versatile functions, structures, and protein characteristics. Sixty percent of the known flavoproteins are involved in human diseases and disorders emphasizing their importance in human metabolism <xref rid="febs13828-bib-0001" ref-type="ref">1</xref>. The human mitochondrial matrix flavoprotein dimethylglycine dehydrogenase (hDMGDH, <ext-link ext-link-type="uri" xlink:href="http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/5/8/4.html">EC: 1.5.8.4</ext-link>) catalyzes the oxidative demethylation of dimethylglycine (DMG) to sarcosine, and also to a lesser extent the conversion of sarcosine to glycine as part of choline degradation (Fig. <xref rid="febs13828-fig-0001" ref-type="fig">1</xref>) <xref rid="febs13828-bib-0002" ref-type="ref">2</xref>, <xref rid="febs13828-bib-0003" ref-type="ref">3</xref>. Choline is an essential nutrient and building block in a variety of vital biomolecules such as the membrane phospholipid phosphatidylcholine and the neurotransmitter acetylcholine <xref rid="febs13828-bib-0004" ref-type="ref">4</xref>. Degradation of choline proceeds by consecutive oxidations via betaine aldehyde, betaine, dimethylglycine, and sarcosine to the amino acid glycine (Fig. <xref rid="febs13828-fig-0001" ref-type="fig">1</xref>) <xref rid="febs13828-bib-0005" ref-type="ref">5</xref>. hDMGDH, a key enzyme of this pathway, requires two cofactors: flavin adenine dinucleotide (FAD) and tetrahydrofolate (THF). The FAD is covalently attached via its 8Î±âposition to the N3 of a histidyl residue and serves as the electron acceptor in the oxidation of DMG. On the other hand, THF is used as the acceptor of the incipient methyl group and thus prevents the release of cellâtoxic formaldehyde during catalysis <xref rid="febs13828-bib-0003" ref-type="ref">3</xref>, <xref rid="febs13828-bib-0006" ref-type="ref">6</xref>. In the course of this reaction, <italic>N</italic>â5,10âmethylene tetrahydrofolate is formed, which plays an important role in oneâcarbon metabolism. Regeneration of oxidized FAD is achieved by electron transfer to the human electronâtransferring flavoprotein (hETF), which in turn transfers the electrons to the membraneâanchored ETFâubiquinone oxidoreductase (ETFâQO) for further utilization in the mitochondrial respiratory chain <xref rid="febs13828-bib-0007" ref-type="ref">7</xref>, <xref rid="febs13828-bib-0008" ref-type="ref">8</xref>.</p>
      <fig fig-type="Figure" xml:lang="en" id="febs13828-fig-0001" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Mammalian choline degradation pathway with <styled-content style="fixed-case">DMGDH</styled-content> as metabolic branch point. Choline degradation to dimethylglycine is catalyzed by three enzymes, choline dehydrogenase (<styled-content style="fixed-case">CHD</styled-content>), betaine aldehyde dehydrogenase (<styled-content style="fixed-case">BAD</styled-content>), and betaine homocysteine <italic>S</italic>âmethyltransferase (<styled-content style="fixed-case">BHMT</styled-content>). Conversion of dimethylglycine (<styled-content style="fixed-case">DMG</styled-content>) to sarcosine by <styled-content style="fixed-case">DMGDH</styled-content> reduces the <styled-content style="fixed-case">FAD</styled-content> cofactor and a methyl group is donated to <styled-content style="fixed-case">THF</styled-content> resulting in <styled-content style="fixed-case">FADH</styled-content>
<sub>2</sub> and <italic>N</italic>â5,10âmethyleneâ<styled-content style="fixed-case">THF</styled-content>. The enzyme is reoxidized by the interaction with <styled-content style="fixed-case">hETF</styled-content> and the derived electrons are further channeled by <styled-content style="fixed-case">ETF</styled-content>â<styled-content style="fixed-case">QO</styled-content> to the mitochondrial respiratory chain. <italic>N</italic>â5,10âmethyleneâ<styled-content style="fixed-case">THF</styled-content> is consumed in further reactions catalyzed by methyleneâ<styled-content style="fixed-case">THF</styled-content> reductase (<styled-content style="fixed-case">MTHFR</styled-content>) and serine hydroxymethyltransferase (<styled-content style="fixed-case">SHMT</styled-content>). <styled-content style="fixed-case">DMGDH</styled-content> is the only enzyme converting dimethylglycine to sarcosine and the only other known route to sarcosine is via glycine <italic>N</italic>âmethyl transferase (<styled-content style="fixed-case">GNMT</styled-content>). Sarcosine is further converted to glycine, mostly by sarcosine dehydrogenase (<styled-content style="fixed-case">SARDH</styled-content>), and is also a substrate for dimethylglycine dehydrogenase and peroxisomal sarcosine oxidase (PIPOX).</p>
        </caption>
        <graphic id="nlm-graphic-3" xlink:href="FEBS-283-3587-g001"/>
      </fig>
      <p>A rare naturally occurring point mutation found in 58 out of 118 656 (0.049%) analyzed human gene sequences (Exome Aggregation Consortium online browser; <ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/variant/5-78351682-T-C">http://exac.broadinstitute.org/variant/5-78351682-T-C</ext-link>) results in the exchange of histidine 109 to arginine (H109R). This variant reportedly suffers from lower stability and enzymatic activity <xref rid="febs13828-bib-0009" ref-type="ref">9</xref>, <xref rid="febs13828-bib-0010" ref-type="ref">10</xref>. The observed phenotype was described as dimethylglycine dehydrogenase deficiency with significantly higher levels of dimethylglycine in human body fluids causing muscle fatigue and a fishâlike odor (OMIM: 605850). Interestingly, the mutation is predominantly found in individuals of African descent.</p>
      <p>In recent years, also the product of the reaction catalyzed by hDMGDH, sarcosine, attracted attention as a biomarker for aggressive prostate cancer <xref rid="febs13828-bib-0011" ref-type="ref">11</xref>, <xref rid="febs13828-bib-0012" ref-type="ref">12</xref>. Therefore, investigations on the regulation of sarcosine levels and the enzymes involved are in the focus of research. Furthermore, a recent epidemiological study revealed a possible connection of dimethylglycine dehydrogenase deficiency to the development of diabetes, further emphasizing the importance of the enzyme <xref rid="febs13828-bib-0013" ref-type="ref">13</xref>.</p>
      <p>Dimethylglycine dehydrogenase (DMGDH) was first identified and purified from rat liver in the 1950s and early 1960s <xref rid="febs13828-bib-0014" ref-type="ref">14</xref>, <xref rid="febs13828-bib-0015" ref-type="ref">15</xref>. Since then several publications have dealt with the characterization of mammalian dimethylglycine dehydrogenases from rat <xref rid="febs13828-bib-0002" ref-type="ref">2</xref>, <xref rid="febs13828-bib-0003" ref-type="ref">3</xref>, <xref rid="febs13828-bib-0016" ref-type="ref">16</xref> and pig liver <xref rid="febs13828-bib-0008" ref-type="ref">8</xref> as well as the recombinant rat <xref rid="febs13828-bib-0017" ref-type="ref">17</xref>, <xref rid="febs13828-bib-0018" ref-type="ref">18</xref> and human enzyme <xref rid="febs13828-bib-0019" ref-type="ref">19</xref> using <italic>Escherichia coli</italic> as expression host. Furthermore, dimethylglycine oxidase from <italic>Arthrobacter globiformis</italic> (<italic>Ag</italic>DMGO) was characterized in biochemical and structural detail <xref rid="febs13828-bib-0006" ref-type="ref">6</xref>, <xref rid="febs13828-bib-0020" ref-type="ref">20</xref>, <xref rid="febs13828-bib-0021" ref-type="ref">21</xref>, <xref rid="febs13828-bib-0022" ref-type="ref">22</xref>, <xref rid="febs13828-bib-0023" ref-type="ref">23</xref>. However, the available information on the hDMGDH appears insufficient and partly contradictory. In order to overcome these deficiencies, we present a profound analysis of the recombinant hDMGDH and the H109R variant concerning kinetics, redox behavior, and spectral properties. Furthermore, we have elucidated the crystal structure of the human wildâtype enzyme.</p>
      <p>In order to characterize hDMGDH, we have established a recombinant expression system for the wildâtype and the H109R variant in <italic>Komagataella phaffii</italic> (formerly known as <italic>Pichia pastoris</italic> or <italic>Komagataella pastoris</italic>
<xref rid="febs13828-bib-0024" ref-type="ref">24</xref>) and a subsequent purification protocol. This approach enabled us to determine key kinetic parameters as well as physical and spectroscopic properties of wildâtype DMGDH. Consequently, we have also employed our expression system to generate the H109R variant to address the putative loss of function that leads to DMGDHâdeficiency in humans. Moreover, successful crystallization of the WT and subsequent crystallographic analysis provided us with the opportunity to analyze the structure with regard to substrate binding and oxygen reactivity. The latter issue is especially interesting as the control of oxygen reactivity in flavoenzymes is still a controversial topic. The direct comparison of a dehydrogenase (hDMGDH) and an oxidase (<italic>Ag</italic>DMGO) allowed new insights into the structural elements involved in oxygen reactivity and supports concepts that are based on gatekeeper residues in the vicinity of the isoalloxazine ring system. In this vein, we show that a previously proposed model to rationalize oxygen reactivity in the vanillyl oxidase family is applicable to the family of sarcosine and dimethylglycine dehydrogenases and oxidases, respectively <xref rid="febs13828-bib-0025" ref-type="ref">25</xref>, <xref rid="febs13828-bib-0026" ref-type="ref">26</xref>.</p>
    </sec>
    <sec id="febs13828-sec-0004">
      <title>Results</title>
      <sec id="febs13828-sec-0005">
        <title>Enzyme expression and purification</title>
        <p>Initial attempts to express the gene encoding hDMGDH in <italic>Escherichia coli</italic> (BL21 DE3) yielded largely insoluble protein. On the other hand, heterologous expression in the methanotrophic yeast <italic>Komagataella phaffi</italic> (formerly known as <italic>Pichia pastoris</italic>
<xref rid="febs13828-bib-0024" ref-type="ref">24</xref>) was successful. As shown in Fig. <xref rid="febs13828-fig-0002" ref-type="fig">2</xref>A, western blot analysis of <italic>K. phaffii</italic> cell lysates at different time points indicates a stable expression of the protein after induction with methanol (MeOH). Typically, fermentations were stopped after 96 h after MeOH induction resulting in 1.6â1.9 kg of wet cell pellet. A comparison of signal intensities showed that the WT was expressed in higher amounts than the variant under identical fermentation conditions thus leading to a higher yield of WT (Fig. <xref rid="febs13828-fig-0002" ref-type="fig">2</xref>A). After cell disruption and NiâNTA affinity chromatography, the yield of proteins (Fig. <xref rid="febs13828-fig-0002" ref-type="fig">2</xref>B, lanes 3) was approximately 70 and 25 mg of the WT and H109R variant, respectively (40 or 15 Î¼g enzyme per g wet cell weight). In order to achieve higher purity for crystallization trials, the proteins were further purified using anion exchange chromatography (Fig. <xref rid="febs13828-fig-0002" ref-type="fig">2</xref>B, lanes 4) resulting in lower protein yields of 30 and 2 mg (17 or 1 Î¼g enzyme per g wet cell weight) of WT and H109R variant, respectively. The protein loss mainly occurred during the necessary buffer change to lower salt concentrations after NiâNTA affinity chromatography required for the subsequent anion exchange chromatography. Although we experienced that hDMGDH tends to precipitate at low salt concentrations, other chromatographic methods, like sizeâexclusion chromatography or hydrophobic interaction chromatography, were explored but did not give a similar purity.</p>
        <fig fig-type="Figure" xml:lang="en" id="febs13828-fig-0002" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Heterologous expression and purification of <styled-content style="fixed-case">hDMGDH</styled-content>â<styled-content style="fixed-case">WT</styled-content> and <styled-content style="fixed-case">hDMGDH</styled-content>âH109R variant. (A) Western blot of <italic>K. phaffii</italic> cell lysates taken at different time points after methanol induction. Antibodies are directed against a Câterminal nonaâhistidine tag fused to the recombinant enzymes and, as loading control, against <italic>K. phaffii </italic>
<styled-content style="fixed-case">GAPDH</styled-content>. (B) <styled-content style="fixed-case">SDS</styled-content>/<styled-content style="fixed-case">PAGE</styled-content> of the different purification steps of <styled-content style="fixed-case">WT</styled-content> and variant shows efficient enzyme purification with Niâ<styled-content style="fixed-case">NTA</styled-content> affinity and MonoQ anion exchange chromatography. <italic>Lane 1</italic>, fermentation pellet fraction; <italic>2</italic>,<italic> K. phaffii</italic> lysate; <italic>3</italic>, enzyme fraction after Niâ<styled-content style="fixed-case">NTA</styled-content> affinity chromatography; <italic>4</italic>, enzyme fraction after Mono Q; <italic>5</italic>, protein standard. (C) <styled-content style="fixed-case">UV</styled-content>âVis absorption spectra of <styled-content style="fixed-case">DMGDH</styled-content> wildâtype (black line) and the H109R variant (red line) after anion exchange chromatography. The spectra were normalized to the longâwavelength absorption maxima (445 and 450 nm, respectively). Free <styled-content style="fixed-case">FAD</styled-content> in solution is shown as a dotted blue line.</p>
          </caption>
          <graphic id="nlm-graphic-5" xlink:href="FEBS-283-3587-g002"/>
        </fig>
        <p>The <italic>A</italic>
<sub>280</sub>/<italic>A</italic>
<sub>450</sub> ratios of the highly pure protein fractions were usually between 14â16 and 20â25 for the WT and variant protein, respectively. The UVâVis absorption spectra show a clear difference between enzymeâbound FAD and free FAD (Fig. <xref rid="febs13828-fig-0002" ref-type="fig">2</xref>C), whereas hDMGDHâWT and the variant featured similar spectral properties with identical absorption maxima. In comparison with free FAD in solution, the UVâVis absorption maxima of FAD bound to either WT or the H109R variant exhibit a hypsochromic shift from 370 to 350 nm and a bathochromic shift from 445 to 460 nm (Fig. <xref rid="febs13828-fig-0002" ref-type="fig">2</xref>C).</p>
      </sec>
      <sec id="febs13828-sec-0006">
        <title>Determination of kinetic parameters for hDMGDHâWT and H109R variant</title>
        <p>The evaluation of the steadyâstate kinetic parameters for hDMGDHâWT and H109R variant was conducted using either ferrocene or 2,6âdichlorophenolindophenol (DCPIP) as electron acceptor to oxidize the reduced FAD cofactor. The obtained parameters show significant differences between the two assay systems both in terms of the <italic>k</italic>
<sub>cat</sub> as well as the <italic>K</italic>
<sub>M</sub> for DMG (Fig. <xref rid="febs13828-fig-0003" ref-type="fig">3</xref>, Table <xref rid="febs13828-tbl-0001" ref-type="table-wrap">1</xref>). When ferrocene was used as the artificial electron acceptor the <italic>k</italic>
<sub>cat</sub> was fivefold greater than with DCPIP (213 Â± 4 versus 44 Â± 1 min<sup>â1</sup>, Table <xref rid="febs13828-tbl-0001" ref-type="table-wrap">1</xref>) and the <italic>K</italic>
<sub>M</sub> was significantly higher (1.4 Â± 0.1 versus 0.3 Â± 0.002 m<sc>m</sc>, Table <xref rid="febs13828-tbl-0001" ref-type="table-wrap">1</xref>). Interestingly, the H109R variant exhibited a twofold higher activity than the WT in both assays. At the same time, the <italic>K</italic>
<sub>M</sub> of DMG was strongly increased by a factor of 23 and 16 in the ferrocene and DCPIP assay, respectively, resulting in an approximately 10âfold lower catalytic efficiency of the H109R variant (Table <xref rid="febs13828-tbl-0001" ref-type="table-wrap">1</xref>). Notably, when DCPIP was used as electron acceptor, data linearization using the method of Eadie and Hofstee revealed a second, much higher <italic>K</italic>
<sub>M</sub> value of â 30 m<sc>m</sc> for DMG (inset Fig. <xref rid="febs13828-fig-0003" ref-type="fig">3</xref>A). As the rate at which FAD is oxidized by ferrocene is closer to the rate of flavin reduction, it appears that ferrocene is superior to DCPIP as electron acceptor.</p>
        <fig fig-type="Figure" xml:lang="en" id="febs13828-fig-0003" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Steadyâstate kinetics of <styled-content style="fixed-case">hDMGDH</styled-content>â<styled-content style="fixed-case">WT</styled-content> and H109R variant. Steadyâstate kinetic experiments were performed with DCPIP (A) and ferrocene activity assays (B) by plotting initial reaction velocities (<italic>v</italic>
<sub>0</sub>) against the substrate concentration. Data obtained for <styled-content style="fixed-case">WT</styled-content> and H109R variant are represented in black and red, respectively. Kinetic parameters are summarized in Table <xref rid="febs13828-tbl-0001" ref-type="table-wrap">1</xref>. Linearization of the data in EadieâHofstee diagrams reveals two <styled-content style="fixed-case"><italic>K</italic><sub>M</sub></styled-content> values for the DCPIP assay, one at low (0â10 m<sc>m </sc>
<styled-content style="fixed-case">DMG</styled-content>) and one at very high substrate concentrations (&gt; 50 m<sc>m </sc>
<styled-content style="fixed-case">DMG</styled-content>, inset panel A). In contrast, the ferrocene assay produced a single <styled-content style="fixed-case"><italic>K</italic><sub>M</sub></styled-content> value when measured in the same concentration range (inset panel B). Error bars are shown as standard deviations; <italic>n</italic> = 3.</p>
          </caption>
          <graphic id="nlm-graphic-7" xlink:href="FEBS-283-3587-g003"/>
        </fig>
        <table-wrap id="febs13828-tbl-0001" xml:lang="en" orientation="portrait" position="float">
          <label>Table 1</label>
          <caption>
            <p>Summary of kinetic parameters obtained with steadyâstate kinetics for hDMGDHâWT and hDMGDHâH109R variant with two different activity assays (DCPIP and ferrocene)</p>
          </caption>
          <table frame="hsides" rules="groups">
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <thead valign="top">
              <tr style="border-bottom:solid 1px #000000">
                <th align="left" valign="top" rowspan="1" colspan="1"/>
                <th align="center" valign="top" rowspan="1" colspan="1">
<italic>K</italic>
<sub>M</sub> (m<sc>m</sc>)</th>
                <th align="center" valign="top" rowspan="1" colspan="1">
<italic>v</italic>
<sub>max</sub> (Î¼<sc>m</sc>Â·min<sup>â1</sup>)</th>
                <th align="center" valign="top" rowspan="1" colspan="1">
<italic>k</italic>
<sub>cat</sub> (min<sup>â1</sup>)</th>
                <th align="center" valign="top" rowspan="1" colspan="1">
<italic>A</italic>
<sub>spec</sub> (Î¼molÂ·mg<sup>â1</sup>Â·min<sup>â1</sup>)</th>
                <th align="center" valign="top" rowspan="1" colspan="1">
<italic>k</italic>
<sub>cat</sub>/<italic>K</italic>
<sub>M</sub> (m<sc>m</sc>
<sup>â1</sup>Â·min<sup>â1</sup>)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">WT DCPIP</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">
0.3 Â± 0.002<break/>
~ 30<xref ref-type="fn" rid="febs13828-note-0001">a</xref>
</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">
4.7 Â± 0.1<break/>
~ 11<xref ref-type="fn" rid="febs13828-note-0001">a</xref>
</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">44 Â± 1</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">0.5 Â± 0.01</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">146 Â± 12</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">WT ferrocene</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">1.4 Â± 0.1</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">22.1 Â± 0.3</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">213 Â± 4</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">2.0 Â± 0.04</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">137 Â± 16</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">H109R DCPIP</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">
4.7 Â± 0.4<break/>
~ 90<xref ref-type="fn" rid="febs13828-note-0001">a</xref>
</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">
7.4 Â± 0.3<break/>
~ 22<xref ref-type="fn" rid="febs13828-note-0001">a</xref>
</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">91 Â± 4</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">1 Â± 0.04</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">20 Â± 2</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">H109R ferrocene</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">32.2 Â± 5.6</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">44.1 Â± 3.2</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">544 Â± 40</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">6 Â± 0.4</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">11 Â± 1</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="febs13828-note-0001">
              <label>a</label>
              <p>Two <italic>K</italic>
<sub>M</sub> and <italic>v</italic>
<sub>max</sub> values were obtained with the DCPIP, the higher was roughly estimated from EadieâHofstee plots (Fig. <xref rid="febs13828-fig-0003" ref-type="fig">3</xref>).</p>
            </fn>
          </table-wrap-foot>
          <permissions>
            <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
          </permissions>
        </table-wrap>
        <p>Due to much lower enzyme amounts available of the H109R variant, presteadyâstate kinetics were solely measured with the wildâtype enzyme. As shown in Fig. <xref rid="febs13828-fig-0004" ref-type="fig">4</xref>A, the rate of reduction as a function of DMG concentration fitted to a hyperbolic equation yielding a limiting reductive rate of 17 Â± 0.3 s<sup>â1</sup> and a dissociation constant of 4.9 Â± 0.3 m<sc>m</sc> for DMG. Thus, the reductive rate is 5â20 times faster than <italic>k</italic>
<sub>cat</sub> determined in the ferrocene and DCPIP (Table <xref rid="febs13828-tbl-0001" ref-type="table-wrap">1</xref>) indicating that the electron transfer from the reduced FAD to the artificial electron acceptor is rateâlimiting in the assays used to evaluate steadyâstate kinetics. Reoxidation of hDMGDH with airâsaturated buffer proceeds very slowly with an observed rate of reoxidation of 0.006 Â± 0.001 s<sup>â1</sup> at an oxygen concentration of 135 Î¼<sc>m</sc> (inset Fig. <xref rid="febs13828-fig-0004" ref-type="fig">4</xref>A). Rapid reaction measurements with sarcosine yielded a limiting rate of reduction of 0.7 Â± 0.1 s<sup>â1</sup> and a dissociation constant of 280 Â± 10 m<sc>m</sc> clearly indicating that sarcosine is a much poorer substrate than DMG (Fig. <xref rid="febs13828-fig-0004" ref-type="fig">4</xref>A).</p>
        <fig fig-type="Figure" xml:lang="en" id="febs13828-fig-0004" orientation="portrait" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Presteadyâstate kinetics of <styled-content style="fixed-case">hDMGDH</styled-content>â<styled-content style="fixed-case">WT</styled-content>. Reductive and oxidative rates were measured under anoxic conditions with the stopped flow device. (A) Reductive rates were determined for <styled-content style="fixed-case">DMG</styled-content> (black, left axis) and sarcosine (red, right axis). The inset shows the reoxidation of reduced <styled-content style="fixed-case">FAD</styled-content> as a function of time at an oxygen concentration of 10.5% (135 Î¼<sc>m</sc> O<sub>2</sub>) at 460 nm. At least three independent measurements were performed; error bars are shown as standard deviations. (B) Selected absorption spectra of the anoxic reduction of 10 Î¼<sc>m </sc>
<styled-content style="fixed-case">hDMGDH</styled-content>â<styled-content style="fixed-case">WT</styled-content> with 125 m<sc>m </sc>
<styled-content style="fixed-case">DMG</styled-content>. The direction of the change in absorption is depicted by arrows. The top inset shows the absorption change at 460 nm observed by mixing <styled-content style="fixed-case">WT</styled-content> with 125 m<sc>m </sc>
<styled-content style="fixed-case">DMG</styled-content>, and the bottom inset shows the change at 460 nm mixing <styled-content style="fixed-case">WT</styled-content> with 125 m<sc>m</sc> sarcosine.</p>
          </caption>
          <graphic id="nlm-graphic-9" xlink:href="FEBS-283-3587-g004"/>
        </fig>
        <p>Finally, we also studied the effect of THF on the activity of hDMGDH using the ferrocene assay (Fig. <xref rid="febs13828-fig-0005" ref-type="fig">5</xref>). The activity measurements were done similarly to the ferrocene activity assay as described above at 25 Â°C and pH 7.8 in 50 m<sc>m</sc> HEPES/NaOH with 150 m<sc>m</sc> NaCl, 100 n<sc>m</sc> hDMGDH, 1 m<sc>m</sc> DMG, 0.1 m<sc>m</sc> EDTA, and 0.2 m<sc>m</sc> freshly prepared ferrocene in a concentration range of 0â75 Î¼<sc>m</sc> THF. As shown in Fig. <xref rid="febs13828-fig-0005" ref-type="fig">5</xref>, the activity of WT decreases as a function of the THF concentration.</p>
        <fig fig-type="Figure" xml:lang="en" id="febs13828-fig-0005" orientation="portrait" position="float">
          <label>Figure 5</label>
          <caption>
            <p>
<styled-content style="fixed-case">hDMGDH</styled-content>â<styled-content style="fixed-case">WT</styled-content> activity as a function of the <styled-content style="fixed-case">THF</styled-content> concentration. The activity was measured using the ferrocene activity assay. The error bars show the standard deviation of at least three measurements for each <styled-content style="fixed-case">THF</styled-content> concentration.</p>
          </caption>
          <graphic id="nlm-graphic-11" xlink:href="FEBS-283-3587-g006"/>
        </fig>
      </sec>
      <sec id="febs13828-sec-0007">
        <title>Photoreduction and determination of the redox potential of hDMGDH</title>
        <p>Reduction of hDMGDH by DMG shows a monophasic conversion of the oxidized FAD to the twoâelectron reduced dihydroquinone state (Fig. <xref rid="febs13828-fig-0004" ref-type="fig">4</xref>B) without any transient appearance of a semiquinone radical. In contrast to substrate reduction, photoreduction of hDMGDH leads to the anionic (red) flavin semiquinone with a typical absorption maximum at 372 nm (Fig. <xref rid="febs13828-fig-0006" ref-type="fig">6</xref>A). Further photoreduction eventually leads to the fully reduced dihydroquinone (Fig. <xref rid="febs13828-fig-0006" ref-type="fig">6</xref>B), which is directly converted to the oxidized state without the occurrence of a semiquinone upon reaction with molecular dioxygen (Fig. <xref rid="febs13828-fig-0006" ref-type="fig">6</xref>C). This was also seen when reduced hDMGDH was reacted with airâsaturated buffer in the stopped flow device (data not shown).</p>
        <fig fig-type="Figure" xml:lang="en" id="febs13828-fig-0006" orientation="portrait" position="float">
          <label>Figure 6</label>
          <caption>
            <p>Photoreduction and redoxpotential of <styled-content style="fixed-case">hDMGDH</styled-content>â<styled-content style="fixed-case">WT</styled-content>. (A) and (B) show selected absorption spectra of the anoxic photoreduction of the wildâtype enzyme. About 20 Î¼<sc>m</sc> of <styled-content style="fixed-case">hDMGDH</styled-content> was photoreduced in the presence of 1 m<sc>m </sc>
<styled-content style="fixed-case">EDTA</styled-content>, 2 Î¼<sc>m</sc> 5âdeaza <styled-content style="fixed-case">FMN</styled-content>, and 2 Î¼<sc>m</sc> methylviologen. First, the enzyme is reduced to the red semiquinone radical state (A) before proceeding to the typical spectrum of a fully reduced hydroquinone species (B). The admission of oxygen to the enzyme shows that reoxidation does not proceed through a semiquinone redox state and directly yields the oxidized state (C). (D) The redox potential for the <styled-content style="fixed-case">WT</styled-content> was determined with the xanthine/xanthine oxidase system described by Massey <xref rid="febs13828-bib-0027" ref-type="ref">27</xref>. The plot shows the simultaneous reduction of the enzyme and the dye with the double logarithmic evaluation of the data according to Minnaert <xref rid="febs13828-bib-0039" ref-type="ref">39</xref> in the inset. About 20 Î¼<sc>m </sc>
<styled-content style="fixed-case">hDMGDH</styled-content> were reduced at 25 Â°C over 120 min with indigotrisulfonic acid potassium salt. The evaluation for the enzyme was done at 480 nm where the dye does not show a contribution to the absorption. Values for the dye were measured at 600 nm. Initial absorption spectra in all panels are depicted in bold lines, whereas final absorption spectra are shown as dashed lines. Only selected absorption spectra are shown. The direction of the change in absorption is depicted by arrows.</p>
          </caption>
          <graphic id="nlm-graphic-13" xlink:href="FEBS-283-3587-g005"/>
        </fig>
        <p>In order to determine the redox potential of hDMGDH, we employed the xanthine oxidase/xanthine method described by Massey <xref rid="febs13828-bib-0027" ref-type="ref">27</xref> using indigotrisulfonic acid potassium salt as reference dye. The slope of the double logarithmic plot was close to unity indicating that the dye and the flavin receive an equal number of electrons (i.e. two), although the anionic semiquinone radical is clearly observable during the redox titration (Fig. <xref rid="febs13828-fig-0006" ref-type="fig">6</xref>D). The redox potential for the reduction of FAD bound to hDMGDH was calculated from six independent measurements to â93 Â± 1 mV.</p>
      </sec>
      <sec id="febs13828-sec-0008">
        <title>Thermal stability of hDMGDHâWT and hDMGDHâH109R</title>
        <p>The thermal stability of both enzymes was determined using Thermofluor<sup>Â®</sup> and circular dichroism spectroscopy. Thermofluor<sup>Â®</sup> temperature scans from 25 to 95 Â°C showed that the WT and the H109R variant have melting points (<italic>T</italic>
<sub>m</sub>) of 52 Â°C and 47 Â°C, respectively (Fig. <xref rid="febs13828-fig-0007" ref-type="fig">7</xref>A). A similar result was obtained by means of CD spectroscopy yielding a <italic>T</italic>
<sub>m</sub> of 53 Â°C and 47 Â°C, for WT and the variant, respectively (Fig. <xref rid="febs13828-fig-0007" ref-type="fig">7</xref>B). Thus, both independent methods confirm that the variant exhibits reduced thermal stability.</p>
        <fig fig-type="Figure" xml:lang="en" id="febs13828-fig-0007" orientation="portrait" position="float">
          <label>Figure 7</label>
          <caption>
            <p>Thermal stability of <styled-content style="fixed-case">hDMGDH</styled-content>â<styled-content style="fixed-case">WT</styled-content> and the H109R variant. The melting temperatures of wildâtype and the variant enzyme differ significantly when measured with Thermofluor<sup>Â®</sup> (A) or <styled-content style="fixed-case">CD</styled-content> spectroscopy (B). Thermofluor<sup>Â®</sup> was done with 2 Î¼<sc>m</sc> enzyme and the addition of <styled-content style="fixed-case">SYPRO</styled-content> Orange. The change in fluorescence during heating is shown for <styled-content style="fixed-case">WT</styled-content> and H109R variant in black and red lines, respectively. The inset in panel A shows the âd(fluorescence)/<styled-content style="fixed-case">dT</styled-content> derivative curves of the raw data. <styled-content style="fixed-case">CD</styled-content> spectroscopy was done with approximately 6 Î¼<sc>m</sc> enzyme. Mean residue ellipticity (<styled-content style="fixed-case">MRE</styled-content>) was measured every 0.1 Â°C at 208 nm which is shown by blackâ and redâfilled circles for <styled-content style="fixed-case">WT</styled-content> and variant, respectively. The data were fitted with a sigmoidal curve in <sc>origin</sc>. The inset in panel B shows the âd(<styled-content style="fixed-case">MRE</styled-content>)/<styled-content style="fixed-case">dT</styled-content> derivative curves of the sigmoidal fits. The variant (red line) exhibits an inflection point at a lower temperature as the wildâtype (black line) in both measurements.</p>
          </caption>
          <graphic id="nlm-graphic-15" xlink:href="FEBS-283-3587-g007"/>
        </fig>
      </sec>
      <sec id="febs13828-sec-0009">
        <title>Protein structure analysis</title>
        <p>The Xâray crystal structure of hDMGDH was determined at 3.1 Ã resolution (Table <xref rid="febs13828-tbl-0002" ref-type="table-wrap">2</xref>). The crystal belongs to the monoclinic space group (<italic>P</italic>2<sub>1</sub>) and contains two dehydrogenase molecules in the asymmetric unit. The two molecules in the asymmetric unit are very similar to each other with an rmsd of 0.22 Ã calculated after the superposition of 810 out of 828 CÎ±âatoms using the program <sc>pymol</sc> (DeLano Scientific). As previously observed in rDMGDH and also after superposition with the rat enzyme (rmsd of 0.37 Ã calculated for 739 out of 809 CÎ±âatoms), the human enzyme consists of two domains: the FADâbinding domain (Nâterminal domain with residues 46â466) and the folateâbinding domain (Câterminal domain with residues 467â855, Fig. <xref rid="febs13828-fig-0008" ref-type="fig">8</xref>A). The FAD cofactor is covalently attached to the protein through a linkage between N3 of His91 and the 8Î±âmethyl group of the isoalloxazine moiety as confirmed by the crystal structure. The folateâbinding domain can be divided into three subdomains positioned in a âcloverleafââlike arrangement as previously described for the rat enzyme <xref rid="febs13828-bib-0018" ref-type="ref">18</xref>. Subdomain 1 (residues 467â537 and 626â728) contains a Greekâkey motif surrounded by Î±âhelices. Subdomain 2 (residues 538â625 and 729â770) is defined by a fiveâstranded antiparallel Î²âsheet with flanking Î±âhelices. Subdomain 3 (residues 771â850) adopts a jellyroll fold. The structure of the rDMGDH was determined in complex with THF <xref rid="febs13828-bib-0018" ref-type="ref">18</xref>. We also observed some difference electron density in the same area in the folateâbinding domain. Due to the lower resolution of the diffraction data and/or an incomplete occupancy of the ligand, however, this density was not clear enough to unequivocally position a folate molecule. Based on the structural similarity of the two enzymes, it is still very likely that folate binds in the same position (Fig. <xref rid="febs13828-fig-0008" ref-type="fig">8</xref>B).</p>
        <table-wrap id="febs13828-tbl-0002" xml:lang="en" orientation="portrait" position="float">
          <label>Table 2</label>
          <caption>
            <p>Data collection and refinement statistics</p>
          </caption>
          <table frame="hsides" rules="groups">
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <tbody>
              <tr style="border-bottom:solid 1px #000000">
                <td align="left" rowspan="1" colspan="1">Xâray source</td>
                <td align="left" rowspan="1" colspan="1">ID29, ESRF, Grenoble, France</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Wavelength (Ã)</td>
                <td align="left" rowspan="1" colspan="1">0.972</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Temperature (K)</td>
                <td align="left" rowspan="1" colspan="1">100</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Space group</td>
                <td align="left" rowspan="1" colspan="1">
<italic>P</italic>2<sub>1</sub>
</td>
              </tr>
              <tr>
                <td align="left" colspan="2" rowspan="1">Cell dimensions</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">
<italic>a</italic>,<italic> b</italic>,<italic> c</italic> (Ã)</td>
                <td align="left" rowspan="1" colspan="1">83.38, 119.87, 86.47</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Î² (Â°)</td>
                <td align="left" rowspan="1" colspan="1">92.59</td>
              </tr>
              <tr>
                <td align="left" colspan="2" rowspan="1">Resolution (Ã)</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">High resolution shell</td>
                <td align="left" rowspan="1" colspan="1">58.65â3.09 (3.2â3.09)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Total no. reflections</td>
                <td align="left" rowspan="1" colspan="1">86 727 (7935)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Unique no. reflections</td>
                <td align="left" rowspan="1" colspan="1">30 495 (2897)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Multiplicity</td>
                <td align="left" rowspan="1" colspan="1">2.8 (2.7)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Completeness (%)</td>
                <td align="left" rowspan="1" colspan="1">97.7 (93.81)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&lt;I/ÏI&gt;</td>
                <td align="left" rowspan="1" colspan="1">4.81 (1.53)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Wilson Bâfactor</td>
                <td align="left" rowspan="1" colspan="1">47.09</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">
<italic>R</italic>
<sub>merge</sub>
</td>
                <td align="left" rowspan="1" colspan="1">0.2058 (0.6573)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">
<italic>R</italic>
<sub>meas</sub>
</td>
                <td align="left" rowspan="1" colspan="1">0.2531</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CC<sub>1/2</sub>
</td>
                <td align="left" rowspan="1" colspan="1">0.958 (0.604)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">CC*</td>
                <td align="left" rowspan="1" colspan="1">0.989 (0.868)</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">
<italic>R</italic>
<sub>work</sub>/<italic>R</italic>
<sub>free</sub>
</td>
                <td align="left" rowspan="1" colspan="1">17.90/26.93</td>
              </tr>
              <tr>
                <td align="left" colspan="2" rowspan="1">Number of nonhydrogen atoms</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Macromolecules</td>
                <td align="left" rowspan="1" colspan="1">12 782</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Ligands</td>
                <td align="left" rowspan="1" colspan="1">106</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Water</td>
                <td align="left" rowspan="1" colspan="1">6</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Protein residues</td>
                <td align="left" rowspan="1" colspan="1">1617</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Average Bâfactor</td>
                <td align="left" rowspan="1" colspan="1">38.1</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Macromolecules</td>
                <td align="left" rowspan="1" colspan="1">38.2</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Ligands</td>
                <td align="left" rowspan="1" colspan="1">30.1</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Solvent</td>
                <td align="left" rowspan="1" colspan="1">15.2</td>
              </tr>
              <tr>
                <td align="left" colspan="2" rowspan="1">R.m.s. deviations</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Bond lengths (Ã)</td>
                <td align="left" rowspan="1" colspan="1">0.010</td>
              </tr>
              <tr>
                <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Bond angles (Â°)</td>
                <td align="left" rowspan="1" colspan="1">1.37</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Ramachandran outliers (%)</td>
                <td align="left" rowspan="1" colspan="1">0.31</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Ramachandran favored (%)</td>
                <td align="left" rowspan="1" colspan="1">94</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Clashscore</td>
                <td align="left" rowspan="1" colspan="1">9.40</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">PDB</td>
                <td align="left" rowspan="1" colspan="1">
<ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L46">5L46</ext-link>
</td>
              </tr>
            </tbody>
          </table>
          <permissions>
            <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
          </permissions>
        </table-wrap>
        <fig fig-type="Figure" xml:lang="en" id="febs13828-fig-0008" orientation="portrait" position="float">
          <label>Figure 8</label>
          <caption>
            <p>Crystal structure of <styled-content style="fixed-case">hDMGDH</styled-content>. (A) The overall structure of <styled-content style="fixed-case">hDMGDH</styled-content> with the <styled-content style="fixed-case">FAD</styled-content>âbinding domain is shown in deep blue and the folateâbinding domain in raspberry. The <styled-content style="fixed-case">THF</styled-content>âbinding site is depicted with an arrow and the <styled-content style="fixed-case">FAD</styled-content> cofactor is shown in yellow sticks. (B) Superposition of the folateâbinding domains of <styled-content style="fixed-case">DMGDH</styled-content> from human (raspberry) and rat (cyan). The <styled-content style="fixed-case">THF</styled-content> cofactor is shown in blue sticks representation.</p>
          </caption>
          <graphic id="nlm-graphic-17" xlink:href="FEBS-283-3587-g011"/>
        </fig>
      </sec>
    </sec>
    <sec id="febs13828-sec-0010">
      <title>Discussion</title>
      <sec id="febs13828-sec-0011">
        <title>Heterologous enzyme expression and purification</title>
        <p>In this study, we demonstrated that intracellular expression of hDMGDH in <italic>K. phaffii</italic> is feasible and provides enough hDMGDH to perform a detailed biochemical and structural characterization. The expression of the fullâlength protein and a Î50 truncated version as well as secretory expression were unsuccessful. However, an Nâterminal Î28 truncation of the enzyme was expressed successfully representing the mature form of the enzyme lacking its mitochondrial targeting sequence <xref rid="febs13828-bib-0028" ref-type="ref">28</xref>. The intracellular coexpression of the <italic>Saccharomyces cerevisiae</italic> protein disulfide isomerase enzyme resulted in improved protein yields. The expression of hDMGDH in <italic>E. coli</italic> as reported before <xref rid="febs13828-bib-0019" ref-type="ref">19</xref> was unsuccessful and failed to yield detectable amounts of protein as judged by western blotting. A Câterminal nonaâhistidineâtag was added to the gene in order to facilitate purification by means of affinity chromatography. According to the previously published structure of the rat enzyme <xref rid="febs13828-bib-0018" ref-type="ref">18</xref>, this Câterminal tag should not interfere with the native fold of the protein or catalytic activity. Western blot analysis showed that the H109R variant is expressed in lower amounts compared to the WT (Fig. <xref rid="febs13828-fig-0002" ref-type="fig">2</xref>A).</p>
        <p>A theoretical <italic>A</italic>
<sub>280</sub>/<italic>A</italic>
<sub>450</sub> ratio for hDMGDH fully saturated with FAD cofactor can be roughly calculated to 14. The observed <italic>A</italic>
<sub>280</sub>/<italic>A</italic>
<sub>450</sub> ratios of the highly pure proteins, 14â16 and 20â24 for WT and H109R variant, respectively, revealed that the WT is almost fully loaded with the covalently attached FAD. In the case of the variant, the ratio was much higher indicating a much lower saturation compared to the WT (ca. 40â50% apoprotein), similar to previously reported observations <xref rid="febs13828-bib-0019" ref-type="ref">19</xref>. The higher fraction of apoprotein may be responsible for the recurring protein precipitation during purification of the variant. Overall, this led to substantially reduced yields of the variant protein and limited the scope of experiments that could be conducted.</p>
      </sec>
      <sec id="febs13828-sec-0012">
        <title>Spectral characteristics and steadyâstate kinetics of hDMGDH</title>
        <p>Recombinant hDMGDH features characteristic UVâVis absorption properties that clearly distinguish the bound FAD from FAD free in solution (Fig. <xref rid="febs13828-fig-0002" ref-type="fig">2</xref>C). These spectral characteristics are very similar to those reported earlier for DMGDH isolated from rat and pig liver as well as for recombinant <italic>Ag</italic>DMGO <xref rid="febs13828-bib-0008" ref-type="ref">8</xref>, <xref rid="febs13828-bib-0016" ref-type="ref">16</xref>, <xref rid="febs13828-bib-0020" ref-type="ref">20</xref>. In contrast, the UVâVis absorption spectra for heterologously expressed rat DMGDH <xref rid="febs13828-bib-0017" ref-type="ref">17</xref> and human DMGDH <xref rid="febs13828-bib-0019" ref-type="ref">19</xref> are either of very poor quality or apparently lack the spectral features that are typically found in these enzymes. In fact, the only published spectrum of hDMGDH expressed in <italic>E. coli</italic> is very similar to free FAD in solution (compare spectra shown in Fig. <xref rid="febs13828-fig-0009" ref-type="fig">9</xref>).</p>
        <fig fig-type="Figure" xml:lang="en" id="febs13828-fig-0009" orientation="portrait" position="float">
          <label>Figure 9</label>
          <caption>
            <p>Protein spectrum of this study (black line) compared with the published <styled-content style="fixed-case">hDMGDH</styled-content> spectrum (gray line, <xref rid="febs13828-bib-0019" ref-type="ref">19</xref>) and free <styled-content style="fixed-case">FAD</styled-content> in solution (dotted blue line)<bold>.</bold> The published spectrum resembles free <styled-content style="fixed-case">FAD</styled-content> in solution and not our spectral findings.</p>
          </caption>
          <graphic id="nlm-graphic-19" xlink:href="FEBS-283-3587-g008"/>
        </fig>
        <p>A summary of our data and the previously published kinetic steadyâstate data is given in Table <xref rid="febs13828-tbl-0003" ref-type="table-wrap">3</xref>. These values were obtained using two different enzymatic activity assays, on one hand with ferrocenium hexafluorophosphate as electron acceptor and on the other hand, the combination of phenazine methosulfate (PMS) as electron mediator and DCPIP as terminal electron acceptor. Both assays are physiologically irrelevant as all mammalian DMGDHs interact with the electronâtransferring flavoprotein (hETF) for reoxidation of the reduced cofactor. With the ferrocene assay, we have obtained comparable results as reported for the rat enzyme <xref rid="febs13828-bib-0018" ref-type="ref">18</xref> and also for the bacterial DMGO <xref rid="febs13828-bib-0022" ref-type="ref">22</xref>. However, analysis of the data obtained with the PMS/DCPIP yielded two MichaelisâMenten constants similar to previously published data for the rat enzyme <xref rid="febs13828-bib-0016" ref-type="ref">16</xref>, <xref rid="febs13828-bib-0017" ref-type="ref">17</xref>. Interestingly, aside from the results reported by McAndrew <italic>et al</italic>. <xref rid="febs13828-bib-0019" ref-type="ref">19</xref>, two <italic>K</italic>
<sub>M</sub> values were only observed for the two component DCPIP activity assay, with PMS as electron mediator, but not in the one component ferrocene or H<sub>2</sub>O<sub>2</sub> assay suggesting that it is an experimental artifact. In view of this apparent inconsistency, speculations that the presence of two <italic>K</italic>
<sub>M</sub> values reflect the presence of activating or regulatory sites in the enzyme are unwarranted <xref rid="febs13828-bib-0016" ref-type="ref">16</xref>, <xref rid="febs13828-bib-0017" ref-type="ref">17</xref>. Moreover, we have shown that the rate of enzyme reduction is faster than <italic>k</italic>
<sub>cat</sub> indicating that reoxidation is rateâlimiting for turnover in both assays. Thus, the affinity of DMG to hDMGDH is more reliably expressed as the dissociation constant determined in presteadyâstate experiments.</p>
        <table-wrap id="febs13828-tbl-0003" xml:lang="en" orientation="portrait" position="float">
          <label>Table 3</label>
          <caption>
            <p>Comparison of steadyâstate kinetic parameters of published results for the DMGDH from <italic>Homo sapiens</italic> (human), <italic>Rattus norvegicus</italic> (rat), <italic>Sus scrofa</italic> (pig), as well as the dimethylglycine oxidase from <italic>A. globiformis</italic> (<italic>Ag</italic>)</p>
          </caption>
          <table frame="hsides" rules="groups">
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <thead valign="top">
              <tr style="border-bottom:solid 1px #000000">
                <th align="left" valign="top" rowspan="1" colspan="1">Enzyme</th>
                <th align="left" valign="top" rowspan="1" colspan="1">e<sup>â</sup>âAcceptor</th>
                <th align="center" valign="top" rowspan="1" colspan="1">Conditions</th>
                <th align="left" valign="top" rowspan="1" colspan="1">
<italic>K</italic>
<sub>M</sub> (m<sc>m</sc>)</th>
                <th align="left" valign="top" rowspan="1" colspan="1">
<italic>k</italic>
<sub>cat</sub> (min<sup>â1</sup>)</th>
                <th align="left" valign="top" rowspan="1" colspan="1">
<italic>A</italic>
<sub>spec</sub> (Î¼molÂ·mg<sup>â1</sup>Â·min<sup>â1</sup>)</th>
                <th align="center" valign="top" rowspan="1" colspan="1">
<italic>k</italic>
<sub>cat</sub>/<italic>K</italic>
<sub>M</sub> (m<sc>m</sc>
<sup>â1</sup>Â·min<sup>â1</sup>)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">Human â this study</td>
                <td align="left" rowspan="1" colspan="1">DCPIP</td>
                <td align="char" char=" " rowspan="1" colspan="1">pH 7.8, 25 Â°C</td>
                <td align="left" rowspan="1" colspan="1">0.3 Â± 0.002<xref ref-type="fn" rid="febs13828-note-0002">b</xref>
</td>
                <td align="left" rowspan="1" colspan="1">44 Â± 1</td>
                <td align="left" rowspan="1" colspan="1">0.5 Â± 0.01</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">146 Â± 12</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Human â this study</td>
                <td align="left" rowspan="1" colspan="1">Ferrocene</td>
                <td align="char" char=" " rowspan="1" colspan="1">pH 7.8, 25 Â°C</td>
                <td align="left" rowspan="1" colspan="1">1.4 Â± 0.1</td>
                <td align="left" rowspan="1" colspan="1">213 Â± 4</td>
                <td align="left" rowspan="1" colspan="1">2.0 Â± 0.04</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">137 Â± 16</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Human â <xref rid="febs13828-bib-0019" ref-type="ref">19</xref>
</td>
                <td align="left" rowspan="1" colspan="1">Ferrocene</td>
                <td align="char" char=" " rowspan="1" colspan="1">pH 7.5, 25 Â°C</td>
                <td align="left" rowspan="1" colspan="1">0.04 Â± 0.01<xref ref-type="fn" rid="febs13828-note-0002">b</xref>
</td>
                <td align="left" rowspan="1" colspan="1">18 Â± 2</td>
                <td align="left" rowspan="1" colspan="1">0.165<xref ref-type="fn" rid="febs13828-note-0002">a</xref>
</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">450 Â± 110</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Rat â <xref rid="febs13828-bib-0018" ref-type="ref">18</xref>, <xref ref-type="fn" rid="febs13828-note-0002">a</xref>
</td>
                <td align="left" rowspan="1" colspan="1">Ferrocene</td>
                <td align="char" char=" " rowspan="1" colspan="1">pH 7.5, 25 Â°C</td>
                <td align="left" rowspan="1" colspan="1">0.6</td>
                <td align="left" rowspan="1" colspan="1">160</td>
                <td align="left" rowspan="1" colspan="1">nd</td>
                <td align="char" rowspan="1" colspan="1">270</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Rat â <xref rid="febs13828-bib-0017" ref-type="ref">17</xref>, <xref ref-type="fn" rid="febs13828-note-0002">a</xref>
</td>
                <td align="left" rowspan="1" colspan="1">DCPIP</td>
                <td align="char" char=" " rowspan="1" colspan="1">pH 7.0, 30 Â°C</td>
                <td align="left" rowspan="1" colspan="1">0.05<xref ref-type="fn" rid="febs13828-note-0002">b</xref>
</td>
                <td align="left" rowspan="1" colspan="1">12.1</td>
                <td align="left" rowspan="1" colspan="1">0.24</td>
                <td align="char" rowspan="1" colspan="1">nd</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Rat â <xref rid="febs13828-bib-0016" ref-type="ref">16</xref>, <xref ref-type="fn" rid="febs13828-note-0002">a</xref>
</td>
                <td align="left" rowspan="1" colspan="1">DCPIP</td>
                <td align="char" char=" " rowspan="1" colspan="1">pH 7.0, 25 Â°C</td>
                <td align="left" rowspan="1" colspan="1">0.05<xref ref-type="fn" rid="febs13828-note-0002">b</xref>
</td>
                <td align="left" rowspan="1" colspan="1">8.4</td>
                <td align="left" rowspan="1" colspan="1">0.14</td>
                <td align="char" rowspan="1" colspan="1">nd</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Pig â <xref rid="febs13828-bib-0008" ref-type="ref">8</xref>, <xref ref-type="fn" rid="febs13828-note-0002">a</xref>
</td>
                <td align="left" rowspan="1" colspan="1">DCPIP</td>
                <td align="char" char=" " rowspan="1" colspan="1">pH 7.0, 25 Â°C</td>
                <td align="left" rowspan="1" colspan="1">nd</td>
                <td align="left" rowspan="1" colspan="1">nd</td>
                <td align="left" rowspan="1" colspan="1">0.157</td>
                <td align="char" rowspan="1" colspan="1">nd</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">
<italic>Ag</italic> â <xref rid="febs13828-bib-0022" ref-type="ref">22</xref>
</td>
                <td align="left" rowspan="1" colspan="1">O<sub>2</sub>
</td>
                <td align="char" char=" " rowspan="1" colspan="1">pH 8.5, 25 Â°C</td>
                <td align="left" rowspan="1" colspan="1">2.4 Â± 0.2</td>
                <td align="left" rowspan="1" colspan="1">640 Â± 20</td>
                <td align="left" rowspan="1" colspan="1">nd</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">270 Â± 32</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="febs13828-note-0002">
              <p>nd, Not determined or stated in the publication. <sup>a</sup> No standard deviations available. <sup>b</sup> Two <italic>K</italic>
<sub>M</sub> values were observed but only the physiologically relevant is displayed.</p>
            </fn>
          </table-wrap-foot>
          <permissions>
            <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
          </permissions>
        </table-wrap>
      </sec>
      <sec id="febs13828-sec-0013">
        <title>Effects of a naturally occurring H109R enzyme variation</title>
        <p>The rare naturally occurring enzyme variant H109R causes a nonfatal disease called dimethylglycine dehydrogenase deficiency (OMIM: 605850). The defect results in an accumulation of DMG in blood serum and urine, and patients suffer from a mild phenotype including muscle fatigue and fishâlike odor <xref rid="febs13828-bib-0009" ref-type="ref">9</xref>, <xref rid="febs13828-bib-0010" ref-type="ref">10</xref>. During heterologous expression in <italic>K. phaffii</italic>, we noticed decreased expression levels resulting in much lower yields of the variant protein. Further characterization of the variant protein demonstrated lower cofactor saturation and thermal stability. Interestingly, the variant showed elevated turnover rates in both of our assay systems although <italic>K</italic>
<sub>M</sub> values were 15â25 times higher and the catalytic efficiency 10âfold lower than for the WT (Table <xref rid="febs13828-tbl-0001" ref-type="table-wrap">1</xref>). Hence, our results are clearly in contradiction with previously published data <xref rid="febs13828-bib-0019" ref-type="ref">19</xref> that claimed significantly decreased catalytic activity of the H109R variant. As the spectral properties of DMGDH preparations obtained from the <italic>E. coli</italic> expression system lacks the characteristic features typically observed for DMGDH isolated from natural sources (e.g., rat and pig liver), it is conceivable that recombinant DMGDH generated in bacterial host cells suffers from an altered FADâbinding mode, such as noncovalent binding. In fact, the absorption spectrum reported for wildâtype DMGDH and its H109R variant is clearly more similar to that of free FAD (Fig. <xref rid="febs13828-fig-0009" ref-type="fig">9</xref>). In our hands, the bacterial expression system produced solely insoluble protein and therefore analysis of FAD binding to the protein could not be inspected further.</p>
        <p>Previous reports on the structure of bacterial DMGO and rat DMGDH identified a large internal cavity in the protein <xref rid="febs13828-bib-0006" ref-type="ref">6</xref>, <xref rid="febs13828-bib-0018" ref-type="ref">18</xref>. This cavity serves as âreaction chamberâ responsible for substrate delivery to the active site, substrate conversion, as well as intermediate channeling to THF and product formation. The binding site of THF is the only entryâexit point of the protein, which was revealed by MD simulations for the structurally related DMGO <xref rid="febs13828-bib-0006" ref-type="ref">6</xref> and also confirmed by cavity analysis of our structure (Fig. <xref rid="febs13828-fig-0010" ref-type="fig">10</xref>A). In accordance with this interpretation, increasing THF concentrations exhibited a negative effect on the turnover rate (Fig. <xref rid="febs13828-fig-0005" ref-type="fig">5</xref>) as the substrate DMG competes with THF for entrance into the cavity at the THFâbinding site.</p>
        <fig fig-type="Figure" xml:lang="en" id="febs13828-fig-0010" orientation="portrait" position="float">
          <label>Figure 10</label>
          <caption>
            <p>
<styled-content style="fixed-case">hDMGDH</styled-content> internal cavity analysis and effect of H109R variation. (A) Cavity analysis of <styled-content style="fixed-case">hDMGDH</styled-content> done with CASoX in <sc>pymol</sc> without a bound <styled-content style="fixed-case">THF</styled-content> cofactor. The protein cavity is shown in green surface view and the <styled-content style="fixed-case">THF</styled-content>âbinding site indicated by an arrow. (B) Closeâup view of the site of amino acid replacement (i.e., H109R) near the active site of the protein. A cavity analysis at this site was done in the wildâtype enzyme (Hisâ109, blue mesh) and the H109R variant (Argâ109, green surface). The bulky, charged arginine extends into the cavity calculated for the wildâtype protein and potentially reduces the size of the substrate tunnel, thus substrate delivery to the <styled-content style="fixed-case">FAD</styled-content>âbinding site. <styled-content style="fixed-case">FAD</styled-content> cofactor is shown in yellow, the residues at position 109 in green and blue sticks, respectively.</p>
          </caption>
          <graphic id="nlm-graphic-21" xlink:href="FEBS-283-3587-g009"/>
        </fig>
        <p>The consistently (16â to 23âfold) higher <italic>K</italic>
<sub>M</sub> observed in both steadyâstate assays with the variant suggests that replacement of histidine by the bulkier arginine impedes access of DMG to the binding site (Fig. <xref rid="febs13828-fig-0010" ref-type="fig">10</xref>B). On the other hand, the H109R variant possessed higher <italic>k</italic>
<sub>cat</sub> values indicating that the variant is more permissible in transferring electrons from the reduced FAD to the artificial electron acceptors.</p>
        <p>In conclusion, our analysis of the diseaseârelated H109R variant has revealed a lower thermal stability and an approximately 10âfold lower catalytic efficiency (Table <xref rid="febs13828-tbl-0001" ref-type="table-wrap">1</xref>) as major effects of the single amino acid exchange. The diminished protein expression and cofactor saturation found in our expression system may also be relevant for homologous expression of the variant in human cells and thus contribute to the overall reduced DMGDH activity manifested in affected human subjects.</p>
      </sec>
      <sec id="febs13828-sec-0014">
        <title>Substrate specificity, redox behavior, and active site composition</title>
        <p>The overall protein structure and the active site of hDMGDH with the covalently bound FAD as well as the THFâbinding site are very similar to the rat enzyme (PDB ID: <ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PAA">4PAA</ext-link>; <xref rid="febs13828-bib-0018" ref-type="ref">18</xref>), and the structure of <italic>Ag</italic>DMGO <xref rid="febs13828-bib-0021" ref-type="ref">21</xref>. In 2003, <italic>Ag</italic>DMGO could be crystallized with a bound folic acid (PDB ID: <ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PJ6">1PJ6</ext-link>) but additionally also with a bound acetate ion that mimics the negatively charged carboxylate group of DMG (PDB ID: <ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PJ5">1PJ5</ext-link>). Most residues in the active site of <italic>Ag</italic>DMGO described to play a role in catalysis and substrate binding are also present in hDMGDH (Fig. <xref rid="febs13828-fig-0011" ref-type="fig">11</xref>). Docking of DMG and sarcosine to the active site of the hDMGDH structure results in a similar positioning of both substrates (Fig. <xref rid="febs13828-fig-0011" ref-type="fig">11</xref>A,B) and thus do not rationalize the differences observed in affinity and catalytic activity. This binding mode is similar to the acetate moiety in the crystal structure of DMGO (Fig. <xref rid="febs13828-fig-0011" ref-type="fig">11</xref>C). Presteadyâstate measurements comparing DMG and sarcosine as substrate for hDMGDHâWT show a 25âfold decrease of the reductive rate for sarcosine as the substrate and a more than 50âfold higher <italic>K</italic>
<sub>D</sub>. These results are in very good agreement with data obtained for the bacterial DMGO (Table <xref rid="febs13828-tbl-0004" ref-type="table-wrap">4</xref>) <xref rid="febs13828-bib-0022" ref-type="ref">22</xref>. Therefore, sarcosine is a poor but possibly physiologically relevant substrate for the enzyme as already shown previously for the pig enzyme <xref rid="febs13828-bib-0003" ref-type="ref">3</xref> and <italic>Ag</italic>DMGO <xref rid="febs13828-bib-0022" ref-type="ref">22</xref>. On the other hand, sarcosine is apparently oxidized by a homologous sarcosine dehydrogenase (SARDH) <xref rid="febs13828-bib-0016" ref-type="ref">16</xref> and also by peroxisomal sarcosine oxidase (PIPOX) <xref rid="febs13828-bib-0029" ref-type="ref">29</xref>. Therefore, the relative turnover of sarcosine by these three FADâdependent enzymes must await further studies.</p>
        <fig fig-type="Figure" xml:lang="en" id="febs13828-fig-0011" orientation="portrait" position="float">
          <label>Figure 11</label>
          <caption>
            <p>Docking and active site composition of <styled-content style="fixed-case">hDMGDH</styled-content> in comparison with bound acetate in <styled-content style="fixed-case">DMGO</styled-content> structure. <styled-content style="fixed-case">DMG</styled-content> (A) and sarcosine (B) were docked into the active site of <styled-content style="fixed-case">hDMGDH</styled-content> with <sc>autodock/vina</sc>
<xref rid="febs13828-bib-0047" ref-type="ref">47</xref>. The active site of <styled-content style="fixed-case">DMGO</styled-content> with bound acetate (C) was retrieved from <styled-content style="fixed-case">PDB ID</styled-content>: <ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PJ5">1PJ5</ext-link>. The docked substrates and the bound acetate are shown in green, magenta, and black. <styled-content style="fixed-case">FAD</styled-content> is shown in yellow and all residues are depicted in stick representation colored according to the atom type. Key hydrogen bonds are shown with black dotted lines.</p>
          </caption>
          <graphic id="nlm-graphic-23" xlink:href="FEBS-283-3587-g010"/>
        </fig>
        <table-wrap id="febs13828-tbl-0004" xml:lang="en" orientation="portrait" position="float">
          <label>Table 4</label>
          <caption>
            <p>Summary and comparison of transient kinetic data of hDMGDH (this study) with published results from <italic>A. globiformis</italic> DMGO <xref rid="febs13828-bib-0022" ref-type="ref">22</xref>, <xref rid="febs13828-bib-0023" ref-type="ref">23</xref>. Measurements were done in a stopped flow at pH 7.8 and 25 Â°C for hDMGDH and 25 Â°C and pH 8.5 for the bacterial enzyme</p>
          </caption>
          <table frame="hsides" rules="groups">
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <col style="border-right:solid 1px #000000" span="1"/>
            <thead valign="top">
              <tr style="border-bottom:solid 1px #000000">
                <th align="left" valign="top" rowspan="1" colspan="1"/>
                <th align="left" valign="top" rowspan="1" colspan="1">
<italic>K</italic>
<sub>D,DMG</sub> (m<sc>m</sc>)</th>
                <th align="center" valign="top" rowspan="1" colspan="1">
<italic>k</italic>
<sub>red,DMG</sub> (s<sup>â1</sup>)</th>
                <th align="center" valign="top" rowspan="1" colspan="1">
<italic>K</italic>
<sub>D,SAR</sub> (m<sc>m</sc>)</th>
                <th align="center" valign="top" rowspan="1" colspan="1">
<italic>k</italic>
<sub>red,SAR</sub> (s<sup>â1</sup>)</th>
                <th align="left" valign="top" rowspan="1" colspan="1">
<italic>k</italic>
<sub>ox</sub> (m<sc>m</sc>
<sup>â1</sup>Â·s<sup>â1</sup>)</th>
                <th align="left" valign="top" rowspan="1" colspan="1">
<italic>k</italic>
<sub>obs,ox</sub> (s<sup>â1</sup>)</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">hDMGDH</td>
                <td align="left" rowspan="1" colspan="1">4.9 Â± 0.3</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">17 Â± 0.3</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">280 Â± 10</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">0.7 Â± 0.1</td>
                <td align="left" rowspan="1" colspan="1">0.04 Â± 0.01</td>
                <td align="left" rowspan="1" colspan="1">0.006 Â± 0.001<xref ref-type="fn" rid="febs13828-note-0003">b</xref>
</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">
<italic>Ag</italic>DMGO</td>
                <td align="left" rowspan="1" colspan="1">~ 10<xref ref-type="fn" rid="febs13828-note-0003">a</xref>
</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">15 Â± 0.2</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">850 Â± 100</td>
                <td align="char" char="Â±" rowspan="1" colspan="1">0.16 Â± 0.1</td>
                <td align="left" rowspan="1" colspan="1">201</td>
                <td align="left" rowspan="1" colspan="1">26<xref ref-type="fn" rid="febs13828-note-0003">c</xref>
</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="febs13828-note-0003">
              <p>
<sup>a</sup> Retrieved from Table <xref rid="febs13828-tbl-0002" ref-type="table-wrap">2</xref> in <xref rid="febs13828-bib-0023" ref-type="ref">23</xref>. <sup>b</sup> Measured at an oxygen concentration of 135 Î¼<sc>m</sc> with p<sub>O2</sub> = 0.105 bar, K<sub>H,pc</sub> = 791 bar <sc>m</sc>
<sup>â1</sup>
<xref rid="febs13828-bib-0049" ref-type="ref">49</xref> for the substrate reduced enzyme. <sup>c</sup> Estimation from fig. <xref rid="febs13828-fig-0008" ref-type="fig">8</xref> in <xref rid="febs13828-bib-0022" ref-type="ref">22</xref>.</p>
            </fn>
          </table-wrap-foot>
          <permissions>
            <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
          </permissions>
        </table-wrap>
        <p>In the bacterial enzyme, a catalytic dyad, consisting of a histidine and a tyrosine, is responsible for deprotonation of the substrate amine <xref rid="febs13828-bib-0021" ref-type="ref">21</xref>. This catalytic dyad is also present in the human enzyme (Fig. <xref rid="febs13828-fig-0011" ref-type="fig">11</xref>). Furthermore, residues interacting with DMG (and sarcosine) were identified in the structure of hDMGDH (Fig. <xref rid="febs13828-fig-0011" ref-type="fig">11</xref>A). After binding and conversion of the substrate at the active site, an intermediate, most likely a cyclic lactone is channeled through the protein cavity to the THFâbinding site <xref rid="febs13828-bib-0006" ref-type="ref">6</xref>. The THFâbinding sites of mammalian and bacterial enzymes are again very similar and were already extensively discussed by Luka <italic>et al</italic>. <xref rid="febs13828-bib-0018" ref-type="ref">18</xref>.</p>
        <p>Basran <italic>et al</italic>. reported a multistep kinetic model for the reduction of DMGO by DMG. In contrast, the reduction of hDMGDH by DMG was adequately fit by a single exponential equation. The actual measurement of the intermediate cyclic lactone could not be observed, most likely due to its short lifetime as described elsewhere <xref rid="febs13828-bib-0006" ref-type="ref">6</xref>.</p>
        <p>The two dehydrogenases in choline degradation belong to a family of enzymes that delivers electrons to the electron transferring flavoprotein (ETF). Among these clients, only the redox potential for the twoâelectron reduction of human mediumâchain acylâCoA dehydrogenases (hMCAD) was previously determined <xref rid="febs13828-bib-0030" ref-type="ref">30</xref>, <xref rid="febs13828-bib-0031" ref-type="ref">31</xref>. This prompted us to determine the redox potential for the covalently bound FAD in hDMGDH. The obtained value of â93 Â± 1 mV is 40 mV more positive than that of hMCAD (â135 mV <xref rid="febs13828-bib-0030" ref-type="ref">30</xref>, <xref rid="febs13828-bib-0031" ref-type="ref">31</xref>) in agreement with the fact that covalent linkages to the 8âmethyl group increase the redox potential <xref rid="febs13828-bib-0032" ref-type="ref">32</xref>. In any case, the much higher redox potential of hETF (+37 mV for the oxidized/semiquinone couple, <xref rid="febs13828-bib-0033" ref-type="ref">33</xref>) ensures that electrons from hDMGDH are readily transferred to the ETFâbound FAD.</p>
        <p>The rates of reduction determined for hDMGDH are in good agreement with those observed for bacterial DMGO (Table <xref rid="febs13828-tbl-0004" ref-type="table-wrap">4</xref>). In contrast to that, the oxygen reactivity of reduced hDMGDH is more than 300 times lower and apparently physiologically irrelevant as reoxidation by its cognate partner protein hETF proceeds over 30 times faster (P. Augustin, E. Gerstmann and P. Macheroux, unpublished results).</p>
        <p>Recently, a study concerning steric control of dioxygen reduction in enzymes of the vanillylâalcohol oxidase (VAO) family discovered a new âgatekeeperâ residue in berberine bridge enzyme and the pollen allergen Phl p 4 <xref rid="febs13828-bib-0025" ref-type="ref">25</xref>. This gatekeeper appears to control access to an oxyanion hole essential to stabilize reaction intermediates during oxidation of the reduced isoalloxazine ring by dioxygen. In this family, valine was found to grant access to the oxyanion hole, whereas isoleucine denies access <xref rid="febs13828-bib-0025" ref-type="ref">25</xref>. Similarly, Leferink <italic>et al</italic>. discovered that a large number of oxidases in the VAO family contain either a glycine or a proline at a structurally conserved position near the isoalloxazine ring <xref rid="febs13828-bib-0026" ref-type="ref">26</xref>. Although hDMGDH does not belong to the VAO protein superfamily, comparison of the hDMGDH to the <italic>Ag</italic>DMGO structure reveals that hDMGDH features residues typical for dehydrogenases suppressing oxygen reactivity, i.e., an alanine and isoleucine, whereas <italic>Ag</italic>DMGO possesses residues compatible with high oxygen reactivity, i.e., proline and valine (Fig. <xref rid="febs13828-fig-0012" ref-type="fig">12</xref>). Nevertheless, in order to further support, if the emerging concept of how oxygen reactivity is controlled in flavoproteins is applicable to DMGDH, a member of the <sc>dâ</sc>amino acid oxidase (DAO) family of FADâdependent oxidoreductases (pfam: 01266), a detailed mutagenesis study of the concerned residues has to be conducted.</p>
        <fig fig-type="Figure" xml:lang="en" id="febs13828-fig-0012" orientation="portrait" position="float">
          <label>Figure 12</label>
          <caption>
            <p>Active site composition of the oxygenâbinding site of <styled-content style="fixed-case">hDMGDH</styled-content> and <italic>Ag</italic>
<styled-content style="fixed-case">DMGO</styled-content>. The human structure is shown in panel A with the most significant alternated residues on the <italic>siâ</italic>face of the flavin isoalloxazine ring shown in green sticks. The bacterial structure is shown in panel B, important residues are shown in magenta. For a better orientation, the catalytic active histidine on the <italic>reâ</italic>face is also displayed. Panel C shows the alignment of the bacterial and the human enzyme with the supposed gatekeeper residues shown corresponding to the reactive C(4a) carbon of the isoalloxazine ring. All residues are depicted in stick representation, <styled-content style="fixed-case">FAD</styled-content> in yellow and colored according to the atom type.</p>
          </caption>
          <graphic id="nlm-graphic-25" xlink:href="FEBS-283-3587-g012"/>
        </fig>
      </sec>
    </sec>
    <sec id="febs13828-sec-0015">
      <title>Experimental procedures</title>
      <sec id="febs13828-sec-0016">
        <title>Enzymes and reagents</title>
        <p>Restriction enzymes and Phusion DNA polymerase were from Thermo Fisher Scientific (Waltham, MA, USA), purification columns and materials from GE Healthcare (Chalfont St Giles, UK) and saltâfree purified oligos for siteâdirected mutagenesis from VBCâBiotech (Vienna, Austria). Antibodies used for western blot were from Cell Signaling Technology (Cambridge, UK). The redox dye for the determination of the redox potential, indigotrisulfonic acid potassium salt, was from TCI Europe N.V. (Zwijndrecht, Belgium). All other chemicals and media were from Carl Roth GmbH (Karlsruhe, Germany) and SigmaâAldrich (St. Louis, MO, USA) and were of the highest grade available.</p>
      </sec>
      <sec id="febs13828-sec-0017">
        <title>hDMGDH expression strain generation</title>
        <p>hDMGDH and hDMGDHâH109R expression plasmids were designed for intracellular enzyme expression in <italic>Komagataella phaffii</italic> KM71H strain (formerly known as <italic>Pichia pastoris</italic> or <italic>Komagataella pastoris</italic>
<xref rid="febs13828-bib-0024" ref-type="ref">24</xref>). The hDMGDH sequence was codon optimized for expression in <italic>K. phaffii</italic> using GeneOptimizer<sup>Â®</sup> (Thermo Fisher Scientific). In accordance to Binzak <italic>et al</italic>., the sequence of the mature form of hDMGDH (lacking the first 28 amino acids, <xref rid="febs13828-bib-0028" ref-type="ref">28</xref>) was used, flanked with <italic>Xho</italic>I and <italic>Not</italic>I restriction sites. For enzyme expression and purification, a Kozak sequence in front of the start codon (AAAA) and a Câterminal nonaâhistidine tag were added. The designed gene was cloned into a pPICZ B expression vector (Thermo Fisher Scientific) and verified by automated sequencing. The recombinant plasmid was transformed to <italic>K. phaffii</italic> KM71H strain (Thermo Fisher Scientific), harboring a pPICKâPDI vector containing the gene for the protein disulfide isomerase from <italic>Saccharomyces cerevisiae</italic> following the guidelines of the Invitrogen EasySelect<sup>â¢</sup>
<italic>Pichia</italic> Expression Kit (Thermo Fisher Scientific). Positive clones were selected by Zeocin resistance and verified by western blot. The H109R variant was constructed by a twoâstep siteâdirected mutagenesis method employing Phusion DNA polymerase and 5â²âAACTTGAAGAAGATC<underline underline-style="single">AGA</underline>TACGACTCCATCAAGâ3â² as forward and 5â²âCTTGATGGAGTCGTA<underline underline-style="single">TCT</underline>GATCTTCTTCAAGTTâ3â² as reverse primer (alternated codon underlined). For the first reaction step, two separate PCR reactions using either the forward or the reverse primer were run with the PCR program: 98 Â°C (2 min) â [98 Â°C (50 s) â 60 Â°C (20 s) â 68 Â°C (16.5 min)] Ã 5 â 4 Â°C â. Afterwards, the two PCR reactions were combined and the same program was employed for another 20 cycles. Then, after a 2âh <italic>Dpn</italic>I digestion step, the plasmid was transformed to <italic>Escherichia coli</italic> TOP10 cells for amplification before transformation to <italic>K. phaffii</italic> KM71H [pPICKâPDI]. Strain selection was done as described above.</p>
      </sec>
      <sec id="febs13828-sec-0018">
        <title>Enzyme expression</title>
        <p>hDMGDH and hDMGDHâH109R expression was carried out in a 7âL glass fermenter BBI CT5â2 system (Sartorius, GÃ¶ttingen, Germany). Preparation of inoculum, and preparation of the fermenter, batch, and fedâbatch were carried out as described by Schrittwieser <italic>et al</italic>. <xref rid="febs13828-bib-0034" ref-type="ref">34</xref>. The fermentation medium was a minimal basal salt medium (MgSO<sub>4</sub>Â·7 H<sub>2</sub>O â 1.2 gÂ·L<sup>â1</sup>; K<sub>2</sub>SO<sub>4</sub> â 14.9 gÂ·L<sup>â1</sup>; KOH â 18.2 gÂ·L<sup>â1</sup>; NaCl â 4.13 gÂ·L<sup>â1</sup>; glycerol â 40 gÂ·L<sup>â1</sup>; 85% H<sub>3</sub>PO<sub>4</sub> â 27 mLÂ·L<sup>â1</sup>). After the fedâbatch, the MeOH induction was started by injection of 5 g MeOH directly into the fermenter and afterwards by a stepwise increase in MeOH feed from 0 to 6 gÂ·h<sup>â1</sup> over 2 h. Glycerol feed was reduced from 15 to 6 gÂ·h<sup>â1</sup> over 2 h and a mixed MeOH/glycerol feed was maintained until the end of the fermentation. In total, 400â500 g MeOH was fed to the cultures before harvest after 96 h of induced growth. Samples were taken for western blot analysis at different time points. The cell pellet was collected by centrifugation (2704 <italic><bold>g</bold></italic>, 30 min, 4 Â°C) and stored at â20 Â°C.</p>
      </sec>
      <sec id="febs13828-sec-0019">
        <title>Enzyme purification</title>
        <p>Cell lysates were prepared by Merckenschlager (Braun Biotech International, Melsungen, Germany) glass beads cell homogenization under CO<sub>2</sub> cooling (3âmin disruption steps). For every 1 g harvested wet cell pellet, 2âmL cell lysis buffer (50 m<sc>m</sc> HEPES/NaOH, 150 m<sc>m</sc> NaCl, 35 m<sc>m</sc> imidazole, 1 m<sc>m</sc> PMSF, pH 7.8) and a spatula tip of FAD were added before cell disruption. The lysates were cleared by centrifugation (38 720 <italic><bold>g</bold></italic>, 30 min, 4 Â°C) and filtered through a paper filter. Nickel ion affinity chromatography was done by applying the lysates onto selfâpacked nickelâSepharose 6 Fast Flow columns (GE Healthcare) at 4 Â°C. Afterwards, the material was washed with washing buffer (50 m<sc>m</sc> HEPES/NaOH, 150 m<sc>m</sc> NaCl, 75 m<sc>m</sc> imidazole, pH 7.8) and the enzyme stripped with elution buffer (50 m<sc>m</sc> HEPES/NaOH, 150 m<sc>m</sc> NaCl, 300 m<sc>m</sc> imidazole, pH 7.8). The purification was monitored by SDS/PAGE and fractions containing hDMGDH were concentrated and rebuffered to storage buffer (50 m<sc>m</sc> HEPES/NaOH, 150 m<sc>m</sc> NaCl, pH 7.8) using Amicon ultracentrifugal filter units (50 kDa cutâoff; MerckâMilipore, Darmstadt, Germany). The obtained enzyme purity was sufficient for kinetic and photometric studies of the enzymes. If a higher enzyme purity was needed, especially for protein crystallization, the eluted fractions of the affinity chromatography were rebuffered to buffer A (25 m<sc>m</sc> HEPES/NaOH, 25 m<sc>m</sc> NaCl, pH 7.8), and anion exchange chromatography with a MonoQ 5/50 GL column (GE Healthcare) was done on an ÃKTA FPLC system (GE Healthcare) at 4 Â°C. The protein was eluted with a gradient from 0% to 50% buffer B (25 m<sc>m</sc> HEPES/NaOH, 1 <sc>m</sc> NaCl, pH 7.8). The chromatography was controlled by SDS/PAGE and fractions containing hDMGDH were concentrated and rebuffered to storage buffer as described above. Purification was done identically for the wildâtype and the variant enzyme.</p>
      </sec>
      <sec id="febs13828-sec-0020">
        <title>SDS/PAGE</title>
        <p>Enzyme samples were separated by SDS/PAGE, with 12.5% separation gels (for western blot 10%), under reducing conditions as described by Laemmli <xref rid="febs13828-bib-0035" ref-type="ref">35</xref>. Gels were either used for western blot analysis or stained with Coomassie brilliant blue Râ250 for purification control. As protein standard, a PageRuler Prestained protein ladder (Thermo Fisher Scientific) was employed.</p>
      </sec>
      <sec id="febs13828-sec-0021">
        <title>Western blot</title>
        <p>
<italic>K. phaffii</italic> cell lysates for western blot screening and control of fermentation were prepared by glass bead disruption following the Invitrogen EasySelect<sup>â¢</sup>
<italic>Pichia</italic> Expression Kit manual (p. 42, Thermo Fisher Scientific). Western blot analysis was done on nitrocellulose membranes essentially following the General Protocol for western blotting from BioâRad (Hercules, CA, USA; Bulletin 6376). As antibodies, a rabbit antiâhistidine IgG antibody at 1 : 2000 overnight at 4 Â°C as primary and an HRPâlinked goat antiârabbit IgG antibody at 1 : 5000 for 1 h at room temperature as secondary antibody were used. As loading control, a rabbit antiâGAPDH antibody was used in a 1 : 1000 dilution overnight. Immunoreactive signals were obtained using SuperSignal West Pico Chemiluminescent Substrate (Thermo Fisher Scientific) and detection in a G:BOX (Syngene, Cambridge, UK).</p>
      </sec>
      <sec id="febs13828-sec-0022">
        <title>UVâVis absorption spectroscopy</title>
        <p>UVâVis absorption spectra to assess protein concentration, activity, purity, quality, and cofactor saturation, as well as for steadyâstate kinetic measurements and photoreduction were recorded with a Specord 210 spectrophotometer (Analytik Jena, Jena, Germany).</p>
      </sec>
      <sec id="febs13828-sec-0023">
        <title>Enzyme quantification and calculation of the extinction coefficient</title>
        <p>Protein concentrations of purified hDMGDH enzymes were determined according to the characteristic absorption of bound FAD at 450 nm. The molar extinction coefficient for hDMGDH was calculated using the method described by Macheroux <xref rid="febs13828-bib-0036" ref-type="ref">36</xref> to 11 600 <sc>m</sc>
<sup>â1</sup>Â·cm<sup>â1</sup>.</p>
      </sec>
      <sec id="febs13828-sec-0024">
        <title>Steadyâstate kinetics</title>
        <p>Steadyâstate kinetic parameters were determined using DCPIP according to OkamuraâIkeda <italic>et al</italic>. <xref rid="febs13828-bib-0037" ref-type="ref">37</xref> or ferrocenium hexafluorophosphate (Fc<sup>+</sup>
<mml:math xmlns:mml="https://jats.nlm.nih.gov/ns/archiving/1.0/" id="nlm-math-1"><mml:msubsup><mml:mtext>PF</mml:mtext><mml:mrow><mml:mn>6</mml:mn></mml:mrow><mml:mo>â</mml:mo></mml:msubsup></mml:math>) as described by Lehman <italic>et al</italic>. <xref rid="febs13828-bib-0038" ref-type="ref">38</xref> as terminal electron acceptor and measurable dimension in the spectrophotometer. In short, DCPIP assays were performed at 25 Â°C and pH 7.8 in 50 m<sc>m</sc> HEPES/NaOH, 150 m<sc>m</sc> NaCl, 135 Î¼<sc>m</sc> DCPIP, and 100 n<sc>m</sc> hDMGDH with freshly prepared 3 m<sc>m</sc> phenazine methosulfate (PMS) as intermediate electron mediator and 0â100 m<sc>m</sc> dimethylglycine (DMG) following the change of absorption spectrophotometrically at 600 nm over 3 min. Ferrocenium assays were performed at 25 Â°C at pH 7.8 in 50 m<sc>m</sc> HEPES/NaOH, 150 m<sc>m</sc> NaCl, 0.1 m<sc>m</sc> EDTA, 100 n<sc>m</sc> hDMGDH, 0â100 m<sc>m</sc> DMG, and freshly prepared 0.2 m<sc>m</sc> Fc<sup>+</sup>
<mml:math xmlns:mml="https://jats.nlm.nih.gov/ns/archiving/1.0/" id="nlm-math-2"><mml:msubsup><mml:mtext>PF</mml:mtext><mml:mrow><mml:mn>6</mml:mn></mml:mrow><mml:mo>â</mml:mo></mml:msubsup></mml:math> following the change of absorption at 300 nm over 3 min. For each concentration, at least a triplicate measurement was performed, the initial velocities were determined, and <italic>K</italic>
<sub>M</sub> and <italic>k</italic>
<sub>cat</sub> were assessed by nonlinear hyperbolic fit in <sc>origin</sc> 8.6 (OriginLab Corp., Northampton, MA, USA).</p>
      </sec>
      <sec id="febs13828-sec-0025">
        <title>Presteadyâstate kinetics</title>
        <p>Presteadyâstate reaction kinetics were measured anaerobically with a HiâTech stopped flow instrument (SFâ61DX2; TgK Scientific Limited, BradfordâonâAvon, UK) in a glove box (Belle Technology, Weymouth, UK) at 25 Â°C. For determination of the reductive rates of enzymeâbound FAD, 20 Î¼<sc>m</sc> purified hDMGDH in 50 m<sc>m</sc> HEPES/NaOH, pH 7.8 containing 150 m<sc>m</sc> NaCl was shot against different concentrations of DMG (0.25â250 m<sc>m</sc>) or sarcosine (0â500 m<sc>m</sc>) dissolved in 50 m<sc>m</sc> HEPES/NaOH, 150 m<sc>m</sc> NaCl pH 7.8 and monitored at 460 nm with a KinetaScanT diode array detector (MGâ6560; TgK Scientific Limited). Each concentration was measured in triplicates and the observed rate constants (<italic>k</italic>
<sub>obs</sub>) for different substrate concentrations were calculated using an exponential fitting function in the <sc>kinetic studio</sc> software (TgK Scientific Limited). The dissociation constant (<italic>K</italic>
<sub>D</sub>) was determined by a hyperbolic fitting curve employing <sc>origin</sc> 8.6 (OriginLab Corp.). The oxidative rate (<italic>k</italic>
<sub>ox</sub>) of the enzyme was measured three times at an oxygen concentration of 10.5% O<sub>2</sub> (135 Î¼<sc>m</sc> O<sub>2</sub>), by mixing substrateâreduced hDMGDH with air equilibrated buffer (50 m<sc>m</sc> HEPES/NaOH, 150 m<sc>m</sc> NaCl, pH 7.8).</p>
      </sec>
      <sec id="febs13828-sec-0026">
        <title>Determination of the redox potential</title>
        <p>The redox potential (<italic>E</italic>
<sub>0</sub>) of the enzymeâbound FAD was measured by the dyeâequilibration method using the xanthine/xanthine oxidase system as described by Massey <xref rid="febs13828-bib-0027" ref-type="ref">27</xref>. The concentrations of enzyme and redox dye were chosen in a way that their absorption maxima were in the same range. The reactions were performed with a HiâTech stopped flow device (SFâ61DX2; TgK Scientific Limited). The measurements took place under anaerobic conditions in a glove box (Belle Technology) at 25 Â°C in 50 m<sc>m</sc> HEPES/NaOH, 150 m<sc>m</sc> NaCl, pH 7.0. The simultaneous reduction of FAD and the redox dye was monitored with a KinetaScanT diode array detector (MGâ6560; TgK Scientific Limited). The reaction was started by mixing a solution containing 300 Î¼<sc>m</sc> xanthine, 5 Î¼<sc>m</sc> benzyl viologen, and an appropriate amount of enzyme with a solution containing catalytic amounts of xanthine oxidase (approximately 200 n<sc>m</sc>, from bovine milk, Grade III purity; SigmaâAldrich) and the redox dye indigotrisulfonic acid dipotassium salt (<italic>E</italic>
<sub>0</sub>, pH 7.0, 25 Â°C = â81 mV). The redox potential was calculated using double logarithmic plots, log(ox/red) of the enzyme versus log(ox/red) of the dye, according to Minnaert <xref rid="febs13828-bib-0039" ref-type="ref">39</xref>. A linear leastâsquares fit was done with Excel 2010 (Microsoft, Redmond, WA, USA).</p>
      </sec>
      <sec id="febs13828-sec-0027">
        <title>Anaerobic photoreduction and reoxidation</title>
        <p>Photoreduction of hDMGDH was done according to the procedure reported by Massey and Hemmerich <xref rid="febs13828-bib-0040" ref-type="ref">40</xref>. About 20 Î¼<sc>m</sc> purified enzyme sample in 50 m<sc>m</sc> HEPES/NaOH, pH 7.8 containing 150 m<sc>m</sc> NaCl, 1 m<sc>m</sc> EDTA, 1 Î¼<sc>m</sc> 5âdiazaâFMN, and 2 Î¼<sc>m</sc> methyl viologen were rendered anaerobic by 2âh incubation in sealable quartz cuvettes in a glove box (Belle Technology). Photoirradiation was carried out with a 10 W LED flood light (Luminea, Buggingen, Germany) and cooling of the cuvette to 15 Â°C. Spectra were recorded until no further changes were observed. For reoxidation of the enzyme, the cuvettes were exposed to air oxygen and absorption spectra were recorded until no further changes were observed.</p>
      </sec>
      <sec id="febs13828-sec-0028">
        <title>Temperature stability</title>
        <sec id="febs13828-sec-0029">
          <title>Thermofluor<sup>Â®</sup>
</title>
          <p>The temperature stability of the enzymes was assessed by monitoring the change in fluorescence using the solvatochromic dye SYPRO Orange (SigmaâAldrich) in a Thermofluor<sup>Â®</sup> assay. Thermofluor<sup>Â®</sup> measurements were carried out as reviewed elsewhere <xref rid="febs13828-bib-0041" ref-type="ref">41</xref> in an FX Connect realâtime PCR system (BioâRad) in 25 Î¼L of 50 m<sc>m</sc> HEPES/NaOH, pH 7.8, containing 150 m<sc>m</sc> NaCl, 10 Î¼<sc>m</sc> of enzyme, and 2.5 Î¼L of a 500Ã dilution of a SYPRO Orange Enzyme Gel stain. The samples were preheated to 25 Â°C and then the temperature was increased in 0.5 Â°CÂ·min<sup>â1</sup> steps to 95 Â°C. Fluorescence data were collected using the FRET channel. Melting temperatures (<italic>T</italic>
<sub>m</sub>) were determined using <sc>cfx manager</sc> 3.0 software (BioâRad).</p>
        </sec>
        <sec id="febs13828-sec-0030">
          <title>Circular dichroism spectroscopy</title>
          <p>CD spectra were recorded on a PSâ150J spectropolarimeter (Jasco, GroÃâUmstadt, Germany) using a 0.02 cm waterâjacketed cylindrical cell thermostatically controlled by an external computerâcontrolled water bath (Julabo F25, Seelbach, Germany). Thermal denaturation data were recorded in a temperature range from 25 to 95 Â°C with a heating rate of 1 Â°CÂ·min<sup>â1</sup>, a response of 1 s, and a resolution of 0.1 Â°C. The protein concentration used was approximately 6 Î¼<sc>m</sc> in 50 m<sc>m</sc> HEPES/NaOH, 50 m<sc>m</sc> NaCl, pH 7.8. The melting temperature was estimated as the point of inflection of the temperatureâdependent mean residue ellipticity at 208 nm.</p>
        </sec>
      </sec>
      <sec id="febs13828-sec-0031">
        <title>Crystallization of hDMGDH</title>
        <p>Crystallization experiments were performed with the microbatch method using different commercial crystallization screens [Index and Morpheus Screen from Hampton Research (Aliso Viejo, CA, USA) and Molecular Dimensions (Newmarket, UK), respectively]. Drops were prepared by mixing 0.5 Î¼L of the protein solution (at a concentration of 4 mgÂ·mL<sup>â1</sup> in 25 m<sc>m</sc> HEPES, 25 m<sc>m</sc> NaCl, and 2 m<sc>m</sc> DTT, pH 7.5) with an equal volume of mother liquor using an ORYX 8 pipetting robot (Douglas Instruments, Hungerford, UK). The drops were sealed with a 3 : 1 mixture of paraffin and silicon oil and the trays incubated at 20 Â°C. First crystal clusters were observed after approximately 1 month in various conditions. Further optimization involved dilutions of the original condition using 25 m<sc>m</sc> HEPES, 25 m<sc>m</sc> NaCl, 2 m<sc>m</sc> DTT, pH 7.5. Diffracting hDMGDH crystals were obtained with a 1 : 3 dilution of the original condition H5 of the Morpheus Screen consisting of 10% w/v PEG 20000, 20% v/v PEG MME 550, 0.02 <sc>m</sc> of each amino acid, and 0.1 <sc>m</sc> MOPS/HEPESâNa pH 7.5.</p>
      </sec>
      <sec id="febs13828-sec-0032">
        <title>Data collection and processing</title>
        <p>Xâray diffraction data were collected to a maximum resolution of 3.1 Ã on beam line ID29 (Î» = 0.972 Ã) at the ESRF Grenoble, France. The crystals were monoclinic (space group <italic>P</italic>2<sub>1</sub>) with unitâcell parameters <italic>a</italic> = 83.38 Ã, <italic>b</italic> = 119.87 Ã, <italic>c</italic> = 86.47 Ã, and Î² = 92.6Â°. The data were processed using the <sc>xds</sc> package <xref rid="febs13828-bib-0042" ref-type="ref">42</xref> and the structure was solved by molecular replacement using the structure of the rat dimethylglycine dehydrogenase (PDB ID: <ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PAA">4PAA</ext-link>, 90% sequence identity) <xref rid="febs13828-bib-0018" ref-type="ref">18</xref>. Structure rebuilding and refinement were performed using the programs <sc>coot</sc>
<xref rid="febs13828-bib-0043" ref-type="ref">43</xref> and <sc>phenix</sc>
<xref rid="febs13828-bib-0044" ref-type="ref">44</xref>. The model contained one Bâfactor per amino acid residue. Noncrystallographicâsymmetry (NCS) restraints were applied. A small number of water molecules were added only manually into the most significant electron difference electron density peaks before the last cycle of refinement. Clear electron density was observed for the majority of the amino acids except of the first 18 Nâterminal residues and the 13 Câterminal residues in both chains present in the asymmetric unit. Residual density was interpreted as FAD in both chains. The final structure was validated using <sc>molprobity</sc>
<xref rid="febs13828-bib-0045" ref-type="ref">45</xref>. Detailed statistics pertaining to data processing and structure refinement are summarized in Table <xref rid="febs13828-tbl-0002" ref-type="table-wrap">2</xref>. The atomic coordinates and structure factors have been deposited in the Protein Data Bank under the accession number <ext-link ext-link-type="uri" xlink:href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5L46">5L46</ext-link>.</p>
      </sec>
      <sec id="febs13828-sec-0033">
        <title>
<italic>In silico</italic> procedures</title>
        <p>Figures for structural analyses were prepared using <sc>pymol</sc> (DeLano Scientific, San Carlos, CA, USA <xref rid="febs13828-bib-0046" ref-type="ref">46</xref>). <italic>In silico</italic> mutagenesis of hDMGDH residue H109 to R109 in the crystal structure was performed with the mutagenesis wizard of <sc>pymol</sc> (DeLano Scientific) and subsequent energy minimization using <sc>yasara</sc> (Yasara Biosciences, Vienna, Austria). Docking experiments of DMG and sarcosine into the hDMGDH structure was done using <sc>autodock/vina</sc>
<xref rid="febs13828-bib-0047" ref-type="ref">47</xref> as implemented in <sc>yasara</sc>. Cavity analyses after and before mutagenesis were performed with the LIGSITE algorithm (CASoX plugin of <sc>pymol</sc>, <xref rid="febs13828-bib-0048" ref-type="ref">48</xref>).</p>
      </sec>
    </sec>
    <sec id="febs13828-sec-0035">
      <title>Author contributions</title>
      <p>PA has expressed, purified, and characterized the wildâtype enzyme and the variant; AH, TPK, and KG crystallized proteins and determined the crystal structure of WT hDMGDH; PA and PM designed biochemical experiments and interpreted the data; PA, AH, TPK, KG, and PM wrote the manuscript.</p>
    </sec>
    <sec id="febs13828-sec-0036">
      <title>Conflict of interests</title>
      <p>The authors declare no conflict of interests.</p>
    </sec>
  </body>
  <back>
    <ack id="febs13828-sec-0034">
      <title>Acknowledgements</title>
      <p>This work was supported by a grant from the Austrian Science Foundation (FWF) to KG and PM (Doctoral program âMolecular Enzymologyâ W901). The authors would like to thank the <italic>Exome Aggregation Consortium</italic> and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at <ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/about">http://exac.broadinstitute.org/about</ext-link>.</p>
    </ack>
    <ref-list content-type="cited-references" id="febs13828-bibl-0001">
      <title>References</title>
      <ref id="febs13828-bib-0001">
        <label>1</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0001">
<string-name>
<surname>Lienhart</surname>
<given-names>WD</given-names>
</string-name>, <string-name>
<surname>Gudipati</surname>
<given-names>V</given-names>
</string-name> &amp; <string-name>
<surname>Macheroux</surname>
<given-names>P</given-names>
</string-name> (<year>2013</year>) <article-title>The human flavoproteome</article-title>. <source>Arch Biochem Biophys</source>
<volume>535</volume>, <fpage>150</fpage>â<lpage>162</lpage>.<pub-id pub-id-type="pmid">23500531</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0002">
        <label>2</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0002">
<string-name>
<surname>Wittwer</surname>
<given-names>AJ</given-names>
</string-name> &amp; <string-name>
<surname>Wagner</surname>
<given-names>C</given-names>
</string-name> (<year>1981</year>) <article-title>Identification of the folateâbinding proteins of rat liver mitochondria as dimethylglycine dehydrogenase and sarcosine dehydrogenase. Purification and folateâbinding characteristics</article-title>. <source>J Biol Chem</source>
<volume>256</volume>, <fpage>4102</fpage>â<lpage>4108</lpage>.<pub-id pub-id-type="pmid">6163777</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0003">
        <label>3</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0003">
<string-name>
<surname>Wittwer</surname>
<given-names>AJ</given-names>
</string-name> &amp; <string-name>
<surname>Wagner</surname>
<given-names>C</given-names>
</string-name> (<year>1981</year>) <article-title>Identification of the folateâbinding proteins of rat liver mitochondria as dimethylglycine dehydrogenase and sarcosine dehydrogenase. Flavoprotein nature and enzymatic properties of the purified proteins</article-title>. <source>J Biol Chem</source>
<volume>256</volume>, <fpage>4109</fpage>â<lpage>4115</lpage>.<pub-id pub-id-type="pmid">6163778</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0004">
        <label>4</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0004">
<string-name>
<surname>Ueland</surname>
<given-names>PM</given-names>
</string-name> (<year>2011</year>) <article-title>Choline and betaine in health and disease</article-title>. <source>J Inherit Metab Dis</source>
<volume>34</volume>, <fpage>3</fpage>â<lpage>15</lpage>.<pub-id pub-id-type="pmid">20446114</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0005">
        <label>5</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0005">
<string-name>
<surname>Wittwer</surname>
<given-names>AJ</given-names>
</string-name> (<year>1980</year>) <article-title>Identification of folate binding protein of mitochondria as dimethylglycine dehydrogenase</article-title>. <source>Proc Natl Acad Sci</source>
<volume>77</volume>, <fpage>4484</fpage>â<lpage>4488</lpage>.<pub-id pub-id-type="pmid">6159630</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0006">
        <label>6</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0006">
<string-name>
<surname>Tralau</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Lafite</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Levy</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Combe</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Scrutton</surname>
<given-names>NS</given-names>
</string-name> &amp; <string-name>
<surname>Leys</surname>
<given-names>D</given-names>
</string-name> (<year>2009</year>) <article-title>An internal reaction chamber in dimethylglycine oxidase provides efficient protection from exposure to toxic formaldehyde</article-title>. <source>J Biol Chem</source>
<volume>284</volume>, <fpage>17826</fpage>â<lpage>17834</lpage>.<pub-id pub-id-type="pmid">19369258</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0007">
        <label>7</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0007">
<string-name>
<surname>Ruzicka</surname>
<given-names>FJ</given-names>
</string-name> &amp; <string-name>
<surname>Beinert</surname>
<given-names>H</given-names>
</string-name> (<year>1977</year>) <article-title>A new ironâsulfur flavoprotein of the respiratory chain</article-title>. <source>J Biol Chem</source>
<volume>252</volume>, <fpage>8440</fpage>â<lpage>8445</lpage>.<pub-id pub-id-type="pmid">925004</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0008">
        <label>8</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0008">
<string-name>
<surname>Steenkamp</surname>
<given-names>DJ</given-names>
</string-name> &amp; <string-name>
<surname>Husain</surname>
<given-names>M</given-names>
</string-name> (<year>1982</year>) <article-title>The effect of tetrahydrofolate on the reduction of electron transfer flavoprotein by sarcosine and dimethylglycine dehydrogenases</article-title>. <source>Biochem J</source>
<volume>203</volume>, <fpage>707</fpage>â<lpage>715</lpage>.<pub-id pub-id-type="pmid">6180732</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0009">
        <label>9</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0009">
<string-name>
<surname>Moolenaar</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>PoggiâBach</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Engelke</surname>
<given-names>UFH</given-names>
</string-name>, <string-name>
<surname>Corstiaensen</surname>
<given-names>JMB</given-names>
</string-name>, <string-name>
<surname>Heerschap</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>De Jong</surname>
<given-names>JGN</given-names>
</string-name>, <string-name>
<surname>Binzak</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Vockley</surname>
<given-names>J</given-names>
</string-name> &amp; <string-name>
<surname>Wevers</surname>
<given-names>RA</given-names>
</string-name> (<year>1999</year>) <article-title>Defect in dimethylglycine dehydrogenase, a new inborn error of metabolism: NMR spectroscopy study</article-title>. <source>Clin Chem</source>
<volume>45</volume>, <fpage>459</fpage>â<lpage>464</lpage>.<pub-id pub-id-type="pmid">10102904</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0010">
        <label>10</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0010">
<string-name>
<surname>Binzak</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Vockley</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Jenkins</surname>
<given-names>RB</given-names>
</string-name> &amp; <string-name>
<surname>Vockley</surname>
<given-names>J</given-names>
</string-name> (<year>2000</year>) <article-title>Structure and analysis of the human dimethylglycine dehydrogenase gene</article-title>. <source>Mol Genet Metab</source>
<volume>69</volume>, <fpage>181</fpage>â<lpage>187</lpage>.<pub-id pub-id-type="pmid">10767172</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0011">
        <label>11</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0011">
<string-name>
<surname>Sreekumar</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Poisson</surname>
<given-names>LM</given-names>
</string-name>, <string-name>
<surname>Rajendiran</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Laxman</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Mehra</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lonigro</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Y</given-names>
</string-name>
<italic>et al</italic> (<year>2009</year>) <article-title>Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression</article-title>. <source>Nature</source>
<volume>457</volume>, <fpage>910</fpage>â<lpage>914</lpage>.<pub-id pub-id-type="pmid">19212411</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0012">
        <label>12</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0012">
<string-name>
<surname>Ferro</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Buonerba</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Terracciano</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Lucarelli</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Cosimato</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Bottero</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Deliu</surname>
<given-names>VM</given-names>
</string-name>, <string-name>
<surname>Ditonno</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>PerdonÃ </surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Autorino</surname>
<given-names>R</given-names>
</string-name>
<italic>et al</italic> (<year>2016</year>) <article-title>Biomarkers in localized prostate cancer</article-title>. <source>Future Oncol</source>
<volume>12</volume>, <fpage>399</fpage>â<lpage>411</lpage>.<pub-id pub-id-type="pmid">26768791</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0013">
        <label>13</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0013">
<string-name>
<surname>Magnusson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Clish</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>EngstrÃ¶m</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Nilsson</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Gerszten</surname>
<given-names>RE</given-names>
</string-name> &amp; <string-name>
<surname>Melander</surname>
<given-names>O</given-names>
</string-name> (<year>2015</year>) <article-title>Dimethylglycine deficiency and the development of diabetes</article-title>. <source>Diabetes</source>
<volume>64</volume>, <fpage>3010</fpage>â<lpage>3016</lpage>.<pub-id pub-id-type="pmid">25795213</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0014">
        <label>14</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0014">
<string-name>
<surname>Hoskins</surname>
<given-names>DD</given-names>
</string-name> &amp; <string-name>
<surname>Mackenzie</surname>
<given-names>CG</given-names>
</string-name> (<year>1961</year>) <article-title>Solubilization and electron transfer flavoprtein requirement of mitochondrial sarcosine dehydrogenase and dimethylglycine dehydrogenase</article-title>. <source>J Biol Chem</source>
<volume>236</volume>, <fpage>177</fpage>â<lpage>183</lpage>.<pub-id pub-id-type="pmid">13716069</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0015">
        <label>15</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0015">
<string-name>
<surname>Frisell</surname>
<given-names>WR</given-names>
</string-name> &amp; <string-name>
<surname>Mackenzie</surname>
<given-names>CG</given-names>
</string-name> (<year>1962</year>) <article-title>Separation and purification of sarcosine dehydrogenase and dimethylglycine dehydrogenase</article-title>. <source>J Biol Chem</source>
<volume>237</volume>, <fpage>94</fpage>â<lpage>98</lpage>.<pub-id pub-id-type="pmid">13895406</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0016">
        <label>16</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0016">
<string-name>
<surname>Porter</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Cook</surname>
<given-names>RJ</given-names>
</string-name> &amp; <string-name>
<surname>Wagner</surname>
<given-names>C</given-names>
</string-name> (<year>1985</year>) <article-title>Enzymatic properties of dimethylglycine dehydrogenase and sarcosine dehydrogenase from rat liver</article-title>. <source>Arch Biochem Biophys</source>
<volume>243</volume>, <fpage>396</fpage>â<lpage>407</lpage>.<pub-id pub-id-type="pmid">2417560</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0017">
        <label>17</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0017">
<string-name>
<surname>Brizio</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Brandsch</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Bufano</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Pochini</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Indiveri</surname>
<given-names>C</given-names>
</string-name> &amp; <string-name>
<surname>Barile</surname>
<given-names>M</given-names>
</string-name> (<year>2004</year>) <article-title>Overâexpression in <italic>Escherichia coli</italic>, functional characterization and refolding of rat dimethylglycine dehydrogenase</article-title>. <source>Protein Expr Purif</source>
<volume>37</volume>, <fpage>434</fpage>â<lpage>442</lpage>.<pub-id pub-id-type="pmid">15358367</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0018">
        <label>18</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0018">
<string-name>
<surname>Luka</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Pakhomova</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Loukachevitch</surname>
<given-names>LV</given-names>
</string-name>, <string-name>
<surname>Newcomer</surname>
<given-names>ME</given-names>
</string-name> &amp; <string-name>
<surname>Wagner</surname>
<given-names>C</given-names>
</string-name> (<year>2014</year>) <article-title>Folate in demethylation: the crystal structure of the rat dimethylglycine dehydrogenase complexed with tetrahydrofolate</article-title>. <source>Biochem Biophys Res Commun</source>
<volume>449</volume>, <fpage>392</fpage>â<lpage>398</lpage>.<pub-id pub-id-type="pmid">24858690</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0019">
        <label>19</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0019">
<string-name>
<surname>McAndrew</surname>
<given-names>RP</given-names>
</string-name>, <string-name>
<surname>Vockley</surname>
<given-names>J</given-names>
</string-name> &amp; <string-name>
<surname>Kim</surname>
<given-names>JâJP</given-names>
</string-name> (<year>2008</year>) <article-title>Molecular basis of dimethylglycine dehydrogenase deficiency associated with pathogenic variant H109R</article-title>. <source>J Inherit Metab Dis</source>
<volume>31</volume>, <fpage>761</fpage>â<lpage>768</lpage>.<pub-id pub-id-type="pmid">18937046</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0020">
        <label>20</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0020">
<string-name>
<surname>Meskys</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Harris</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Casaite</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Basran</surname>
<given-names>J</given-names>
</string-name> &amp; <string-name>
<surname>Scrutton</surname>
<given-names>NS</given-names>
</string-name> (<year>2001</year>) <article-title>Organization of the genes involved in dimethylglycine and sarcosine degradation in <italic>Arthrobacter</italic> spp.: implications for glycine betaine catabolism</article-title>. <source>Eur J Biochem</source>
<volume>268</volume>, <fpage>3390</fpage>â<lpage>3398</lpage>.<pub-id pub-id-type="pmid">11422368</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0021">
        <label>21</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0021">
<string-name>
<surname>Leys</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Basran</surname>
<given-names>J</given-names>
</string-name> &amp; <string-name>
<surname>Scrutton</surname>
<given-names>NS</given-names>
</string-name> (<year>2003</year>) <article-title>Channelling and formation of âactiveâ formaldehyde in dimethylglycine oxidase</article-title>. <source>EMBO J</source>
<volume>22</volume>, <fpage>4038</fpage>â<lpage>4048</lpage>.<pub-id pub-id-type="pmid">12912903</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0022">
        <label>22</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0022">
<string-name>
<surname>Basran</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Bhanji</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Basran</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Nietlispach</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Mistry</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Meskys</surname>
<given-names>R</given-names>
</string-name> &amp; <string-name>
<surname>Scrutton</surname>
<given-names>NS</given-names>
</string-name> (<year>2002</year>) <article-title>Mechanistic aspects of the covalent flavoprotein dimethylglycine oxidase of <italic>Arthrobacter globiformis</italic> studied by stoppedâflow spectrophotometry</article-title>. <source>Biochemistry</source>
<volume>41</volume>, <fpage>4733</fpage>â<lpage>4743</lpage>.<pub-id pub-id-type="pmid">11926836</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0023">
        <label>23</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0023">
<string-name>
<surname>Basran</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fullerton</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Leys</surname>
<given-names>D</given-names>
</string-name> &amp; <string-name>
<surname>Scrutton</surname>
<given-names>NS</given-names>
</string-name> (<year>2006</year>) <article-title>Mechanism of FAD reduction and role of active site residues Hisâ225 and Tyrâ259 in <italic>Arthrobacter globiformis</italic> dimethylglycine oxidase: analysis of mutant structure and catalytic function</article-title>. <source>Biochemistry</source>
<volume>45</volume>, <fpage>11151</fpage>â<lpage>11161</lpage>.<pub-id pub-id-type="pmid">16964976</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0024">
        <label>24</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0024">
<string-name>
<surname>Kurtzman</surname>
<given-names>CP</given-names>
</string-name> (<year>2009</year>) <article-title>Biotechnological strains of <italic>Komagataella (Pichia) pastoris</italic> are <italic>Komagataella phaffii</italic> as determined from multigene sequence analysis</article-title>. <source>J Ind Microbiol Biotechnol</source>
<volume>36</volume>, <fpage>1435</fpage>â<lpage>1438</lpage>.<pub-id pub-id-type="pmid">19760441</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0025">
        <label>25</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0025">
<string-name>
<surname>Zafred</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Steiner</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Teufelberger</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Hromic</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Karplus</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Schofield</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Wallner</surname>
<given-names>S</given-names>
</string-name> &amp; <string-name>
<surname>Macheroux</surname>
<given-names>P</given-names>
</string-name> (<year>2015</year>) <article-title>Rationally engineered flavinâdependent oxidase reveals steric control of dioxygen reduction</article-title>. <source>FEBS J</source>
<volume>282</volume>, <fpage>3060</fpage>â<lpage>3074</lpage>.<pub-id pub-id-type="pmid">25619330</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0026">
        <label>26</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0026">
<string-name>
<surname>Leferink</surname>
<given-names>NGH</given-names>
</string-name>, <string-name>
<surname>Fraaije</surname>
<given-names>MW</given-names>
</string-name>, <string-name>
<surname>Joosten</surname>
<given-names>HJ</given-names>
</string-name>, <string-name>
<surname>Schaap</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Mattevi</surname>
<given-names>A</given-names>
</string-name> &amp; <string-name>
<surname>van Berkel</surname>
<given-names>WJH</given-names>
</string-name> (<year>2009</year>) <article-title>Identification of a gatekeeper residue that prevents dehydrogenases from acting as oxidases</article-title>. <source>J Biol Chem</source>
<volume>284</volume>, <fpage>4392</fpage>â<lpage>4397</lpage>.<pub-id pub-id-type="pmid">19088070</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0027">
        <label>27</label>
        <mixed-citation publication-type="book" id="febs13828-cit-0027">
<string-name>
<surname>Massey</surname>
<given-names>V</given-names>
</string-name> (<year>1991</year>) <article-title>A simple method for the determination of redox potentials</article-title>. In <italic>Flavins and Flavoproteins</italic> (<person-group person-group-type="editor"><name><surname>Curti</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Zanetti</surname><given-names>G</given-names></name></person-group> &amp; <person-group person-group-type="editor"><name><surname>Ronchi</surname><given-names>S</given-names></name></person-group>, eds), pp. <fpage>59</fpage>â<lpage>66</lpage>. <publisher-name>Walter de Gruyter</publisher-name>, <publisher-loc>Como, Italy</publisher-loc>.</mixed-citation>
      </ref>
      <ref id="febs13828-bib-0028">
        <label>28</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0028">
<string-name>
<surname>Binzak</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Wevers</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Moolenaar</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>YM</given-names>
</string-name>, <string-name>
<surname>Hwu</surname>
<given-names>WL</given-names>
</string-name>, <string-name>
<surname>PoggiâBach</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Engelke</surname>
<given-names>UF</given-names>
</string-name>, <string-name>
<surname>Hoard</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Vockley</surname>
<given-names>JG</given-names>
</string-name> &amp; <string-name>
<surname>Vockley</surname>
<given-names>J</given-names>
</string-name> (<year>2001</year>) <article-title>Cloning of dimethylglycine dehydrogenase and a new human inborn error of metabolism, dimethylglycine dehydrogenase deficiency</article-title>. <source>Am J Hum Genet</source>
<volume>68</volume>, <fpage>839</fpage>â<lpage>847</lpage>.<pub-id pub-id-type="pmid">11231903</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0029">
        <label>29</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0029">
<string-name>
<surname>Dodt</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>DG</given-names>
</string-name>, <string-name>
<surname>Reimann</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Reuber</surname>
<given-names>BE</given-names>
</string-name>, <string-name>
<surname>McCabe</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Gould</surname>
<given-names>SJ</given-names>
</string-name> &amp; <string-name>
<surname>Mihalik</surname>
<given-names>SJ</given-names>
</string-name> (<year>2000</year>) <article-title>LâPipecolic acid oxidase, a human enzyme essential for the degradation of Lâpipecolic acid, is most similar to the monomeric sarcosine oxidases</article-title>. <source>Biochem J</source>
<volume>345</volume> (<issue>Pt 3</issue>), <fpage>487</fpage>â<lpage>494</lpage>.<pub-id pub-id-type="pmid">10642506</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0030">
        <label>30</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0030">
<string-name>
<surname>Gustafson</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Feinberg</surname>
<given-names>B</given-names>
</string-name> &amp; <string-name>
<surname>McFarland</surname>
<given-names>JT</given-names>
</string-name> (<year>1986</year>) <article-title>Energetics of betaâoxidation. Reduction potentials of general fatty acylâCoA dehydrogenase, electron transfer flavoprotein, and fatty acylâCoA substrates</article-title>. <source>J Biol Chem</source>
<volume>261</volume>, <fpage>7733</fpage>â<lpage>7741</lpage>.<pub-id pub-id-type="pmid">3711105</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0031">
        <label>31</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0031">
<string-name>
<surname>Lenn</surname>
<given-names>ND</given-names>
</string-name>, <string-name>
<surname>Stankovich</surname>
<given-names>MT</given-names>
</string-name> &amp; <string-name>
<surname>Liu</surname>
<given-names>HW</given-names>
</string-name> (<year>1990</year>) <article-title>Regulation of the redox potential of general acylâCoA dehydrogenase by substrate binding</article-title>. <source>Biochemistry</source>
<volume>29</volume>, <fpage>3709</fpage>â<lpage>3715</lpage>.<pub-id pub-id-type="pmid">2340267</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0032">
        <label>32</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0032">
<string-name>
<surname>Fraaije</surname>
<given-names>MW</given-names>
</string-name>, <string-name>
<surname>van den Heuvel</surname>
<given-names>RH</given-names>
</string-name>, <string-name>
<surname>van Berkel</surname>
<given-names>WJ</given-names>
</string-name> &amp; <string-name>
<surname>Mattevi</surname>
<given-names>A</given-names>
</string-name> (<year>1999</year>) <article-title>Covalent flavinylation is essential for efficient redox catalysis in vanillylâalcohol oxidase</article-title>. <source>J Biol Chem</source>
<volume>274</volume>, <fpage>35514</fpage>â<lpage>35520</lpage>.<pub-id pub-id-type="pmid">10585424</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0033">
        <label>33</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0033">
<string-name>
<surname>Salazar</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>deGala</surname>
<given-names>GD</given-names>
</string-name> &amp; <string-name>
<surname>Frerman</surname>
<given-names>FE</given-names>
</string-name> (<year>1997</year>) <article-title>Expression and characterization of two pathogenic mutations in human electron transfer flavoprotein</article-title>. <source>J Biol Chem</source>
<volume>272</volume>, <fpage>26425</fpage>â<lpage>26433</lpage>.<pub-id pub-id-type="pmid">9334218</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0034">
        <label>34</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0034">
<string-name>
<surname>Schrittwieser</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Resch</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Wallner</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Lienhart</surname>
<given-names>WâD</given-names>
</string-name>, <string-name>
<surname>Sattler</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Resch</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Macheroux</surname>
<given-names>P</given-names>
</string-name> &amp; <string-name>
<surname>Kroutil</surname>
<given-names>W</given-names>
</string-name> (<year>2011</year>) <article-title>Biocatalytic organic synthesis of optically pure (S)âscoulerine and berbine and benzylisoquinoline alkaloids</article-title>. <source>J Org Chem</source>
<volume>76</volume>, <fpage>6703</fpage>â<lpage>6714</lpage>.<pub-id pub-id-type="pmid">21739961</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0035">
        <label>35</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0035">
<string-name>
<surname>Laemmli</surname>
<given-names>UK</given-names>
</string-name> (<year>1970</year>) <article-title>Cleavage of structural proteins during the assembly of the head of bacteriophage T4</article-title>. <source>Nature</source>
<volume>227</volume>, <fpage>680</fpage>â<lpage>685</lpage>.<pub-id pub-id-type="pmid">5432063</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0036">
        <label>36</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0036">
<string-name>
<surname>Macheroux</surname>
<given-names>P</given-names>
</string-name> (<year>1999</year>) <article-title>UVâvisible spectroscopy as a tool to study flavoproteins</article-title>. <source>Methods Mol Biol</source>
<volume>131</volume>, <fpage>1</fpage>â<lpage>7</lpage>.<pub-id pub-id-type="pmid">10494538</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0037">
        <label>37</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0037">
<string-name>
<surname>OkamuraâIkeda</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Ikeda</surname>
<given-names>Y</given-names>
</string-name> &amp; <string-name>
<surname>Tanaka</surname>
<given-names>K</given-names>
</string-name> (<year>1985</year>) <article-title>An essential cysteine residue located in the vicinity of the FADâbinding site in shortâchain, mediumâchain, and longâchain acylâCoA dehydrogenases from rat liver mitochondria</article-title>. <source>J Biol Chem</source>
<volume>260</volume>, <fpage>1338</fpage>â<lpage>1345</lpage>.<pub-id pub-id-type="pmid">3968065</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0038">
        <label>38</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0038">
<string-name>
<surname>Lehman</surname>
<given-names>TC</given-names>
</string-name> &amp; <string-name>
<surname>Thorpe</surname>
<given-names>C</given-names>
</string-name> (<year>1990</year>) <article-title>Alternate electron acceptors for mediumâchain acylâCoA dehydrogenase: use of ferricenium salts</article-title>. <source>Biochemistry</source>
<volume>29</volume>, <fpage>10594</fpage>â<lpage>10602</lpage>.<pub-id pub-id-type="pmid">2271671</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0039">
        <label>39</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0039">
<string-name>
<surname>Minnaert</surname>
<given-names>K</given-names>
</string-name> (<year>1965</year>) <article-title>Measurement of the equilibrium constant of the reaction between cytochrome c and cytochrome a</article-title>. <source>Biochim Biophys Acta</source>
<volume>110</volume>, <fpage>42</fpage>â<lpage>56</lpage>.<pub-id pub-id-type="pmid">4286147</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0040">
        <label>40</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0040">
<string-name>
<surname>Massey</surname>
<given-names>V</given-names>
</string-name> &amp; <string-name>
<surname>Hemmerich</surname>
<given-names>P</given-names>
</string-name> (<year>1978</year>) <article-title>Photoreduction of flavoproteins and other biological compounds catalyzed by deazaflavins</article-title>. <source>Biochemistry</source>
<volume>17</volume>, <fpage>9</fpage>â<lpage>16</lpage>.<pub-id pub-id-type="pmid">618550</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0041">
        <label>41</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0041">
<string-name>
<surname>Boivin</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Kozak</surname>
<given-names>S</given-names>
</string-name> &amp; <string-name>
<surname>Meijers</surname>
<given-names>R</given-names>
</string-name> (<year>2013</year>) <article-title>Optimization of protein purification and characterization using Thermofluor screens</article-title>. <source>Protein Expr Purif</source>
<volume>91</volume>, <fpage>192</fpage>â<lpage>206</lpage>.<pub-id pub-id-type="pmid">23948764</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0042">
        <label>42</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0042">
<string-name>
<surname>Kabsch</surname>
<given-names>W</given-names>
</string-name> (<year>2010</year>) <article-title>XDS</article-title>. <source>Acta Crystallogr D</source>
<volume>66</volume>, <fpage>125</fpage>â<lpage>132</lpage>.<pub-id pub-id-type="pmid">20124692</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0043">
        <label>43</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0043">
<string-name>
<surname>Emsley</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Lohkamp</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Scott</surname>
<given-names>WG</given-names>
</string-name> &amp; <string-name>
<surname>Cowtan</surname>
<given-names>K</given-names>
</string-name> (<year>2010</year>) <article-title>Features and development of Coot</article-title>. <source>Acta Crystallogr D</source>
<volume>66</volume>, <fpage>486</fpage>â<lpage>501</lpage>.<pub-id pub-id-type="pmid">20383002</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0044">
        <label>44</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0044">
<string-name>
<surname>Adams</surname>
<given-names>PD</given-names>
</string-name>, <string-name>
<surname>Afonine</surname>
<given-names>PV</given-names>
</string-name>, <string-name>
<surname>BunkÃ³czi</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>VB</given-names>
</string-name>, <string-name>
<surname>Davis</surname>
<given-names>IW</given-names>
</string-name>, <string-name>
<surname>Echols</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Headd</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Hung</surname>
<given-names>LâW</given-names>
</string-name>, <string-name>
<surname>Kapral</surname>
<given-names>GJ</given-names>
</string-name>, <string-name>
<surname>GrosseâKunstleve</surname>
<given-names>RW</given-names>
</string-name>
<italic>et al</italic> (<year>2010</year>) <article-title>PHENIX : a comprehensive Pythonâbased system for macromolecular structure solution</article-title>. <source>Acta Crystallogr D</source>
<volume>66</volume>, <fpage>213</fpage>â<lpage>221</lpage>.<pub-id pub-id-type="pmid">20124702</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0045">
        <label>45</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0045">
<string-name>
<surname>Chen</surname>
<given-names>VB</given-names>
</string-name>, <string-name>
<surname>Arendall</surname>
<given-names>WB</given-names>
</string-name>, <string-name>
<surname>Headd</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Keedy</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Immormino</surname>
<given-names>RM</given-names>
</string-name>, <string-name>
<surname>Kapral</surname>
<given-names>GJ</given-names>
</string-name>, <string-name>
<surname>Murray</surname>
<given-names>LW</given-names>
</string-name>, <string-name>
<surname>Richardson</surname>
<given-names>JS</given-names>
</string-name> &amp; <string-name>
<surname>Richardson</surname>
<given-names>DC</given-names>
</string-name> (<year>2010</year>) <article-title>MolProbity : allâatom structure validation for macromolecular crystallography</article-title>. <source>Acta Crystallogr D</source>
<volume>66</volume>, <fpage>12</fpage>â<lpage>21</lpage>.<pub-id pub-id-type="pmid">20057044</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0046">
        <label>46</label>
        <mixed-citation publication-type="book" id="febs13828-cit-0046">
<string-name>
<surname>DeLano</surname>
<given-names>WL</given-names>
</string-name> (<year>2002</year>) <article-title>The PyMOL molecular graphics system, Version 1.5.0.4</article-title>. <publisher-name>SchrÃ¶dinger, LLC</publisher-name>, <publisher-loc>New York City, NY, USA</publisher-loc>.</mixed-citation>
      </ref>
      <ref id="febs13828-bib-0047">
        <label>47</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0047">
<string-name>
<surname>Trott</surname>
<given-names>O</given-names>
</string-name> &amp; <string-name>
<surname>Olson</surname>
<given-names>AJ</given-names>
</string-name> (<year>2010</year>) <article-title>AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</article-title>. <source>J Comput Chem</source>
<volume>31</volume>, <fpage>455</fpage>â<lpage>461</lpage>.<pub-id pub-id-type="pmid">19499576</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0048">
        <label>48</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0048">
<string-name>
<surname>Hendlich</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rippmann</surname>
<given-names>F</given-names>
</string-name> &amp; <string-name>
<surname>Barnickel</surname>
<given-names>G</given-names>
</string-name> (<year>1997</year>) <article-title>LIGSITE: automatic and efficient detection of potential small moleculeâbinding sites in proteins</article-title>. <source>J Mol Graph Model</source>
<volume>15</volume>, <fpage>359</fpage>â<lpage>363</lpage>.<pub-id pub-id-type="pmid">9704298</pub-id></mixed-citation>
      </ref>
      <ref id="febs13828-bib-0049">
        <label>49</label>
        <mixed-citation publication-type="journal" id="febs13828-cit-0049">
<string-name>
<surname>Sander</surname>
<given-names>R</given-names>
</string-name> (<year>2015</year>) <article-title>Compilation of Henry's law constants (version 4.0) for water as solvent</article-title>. <source>Atmos Chem Phys</source>
<volume>15</volume>, <fpage>4399</fpage>â<lpage>4981</lpage>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>